| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone binding | RNF168 RSF1 TSPYL2 CHD4 SRCAP SUPT6H TAF1 TAF1L PHIP KDM5A RBBP5 HAT1 MORC4 IPO9 | 1.17e-06 | 265 | 215 | 14 | GO:0042393 |
| GeneOntologyMolecularFunction | glycosylceramide flippase activity | 1.23e-06 | 3 | 215 | 3 | GO:0140351 | |
| GeneOntologyMolecularFunction | protein kinase A regulatory subunit binding | 6.16e-06 | 25 | 215 | 5 | GO:0034237 | |
| GeneOntologyMolecularFunction | protein kinase A binding | 3.69e-05 | 58 | 215 | 6 | GO:0051018 | |
| GeneOntologyMolecularFunction | histone modifying activity | RNF168 SRCAP BRCA2 EHMT2 KDM2B TAF1 TAF1L KDM5A HAT1 SUV39H2 TGM2 | 4.02e-05 | 229 | 215 | 11 | GO:0140993 |
| GeneOntologyMolecularFunction | cAMP-dependent protein kinase activity | 4.17e-05 | 7 | 215 | 3 | GO:0004691 | |
| GeneOntologyMolecularFunction | SUMO ligase activity | 5.53e-05 | 20 | 215 | 4 | GO:0061665 | |
| GeneOntologyMolecularFunction | calcium ion binding | CAPN9 EFCAB5 F2 RYR2 FBN2 PROZ CCDC47 PLCD1 STIM2 PCLO PCDHB6 RHOT2 CDH19 MYL12A ESYT3 TGM2 MEGF6 TLL2 SCUBE3 MYL12B CDH11 | 6.29e-05 | 749 | 215 | 21 | GO:0005509 |
| GeneOntologyMolecularFunction | cyclic nucleotide-dependent protein kinase activity | 9.86e-05 | 9 | 215 | 3 | GO:0004690 | |
| GeneOntologyMolecularFunction | phosphatidylcholine phospholipase C activity | 1.15e-04 | 2 | 215 | 2 | GO:0034480 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH2 MYH3 MYH6 RSF1 DDX42 ATP10B CHD4 SRCAP MYO3A HELZ DNAH6 MORC4 FANCM ATP10A ATP10D RAD50 KIF20A TDRD12 | 1.23e-04 | 614 | 215 | 18 | GO:0140657 |
| GeneOntologyMolecularFunction | AMP-activated protein kinase activity | 1.40e-04 | 10 | 215 | 3 | GO:0004679 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 2.17e-04 | 51 | 215 | 5 | GO:0004402 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 3.10e-04 | 55 | 215 | 5 | GO:0061733 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | MYH3 RSF1 DDX42 ATP10B CHD4 SRCAP DNAH6 MORC4 FANCM ATP10A ATP10D RAD50 KIF20A TDRD12 | 3.20e-04 | 441 | 215 | 14 | GO:0016887 |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 4.66e-04 | 60 | 215 | 5 | GO:0034212 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 5.88e-04 | 36 | 215 | 4 | GO:0019789 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 7.24e-04 | 38 | 215 | 4 | GO:0000146 | |
| GeneOntologyMolecularFunction | flippase activity | 7.49e-04 | 17 | 215 | 3 | GO:0140327 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | MYH3 RSF1 DDX42 ATP10B CHD4 SRCAP DNAH6 DNM2 DNM1L RHOT2 MORC4 FANCM ATP10A ATP10D RAD50 KIF20A DNM3 MX1 TDRD12 | 7.49e-04 | 775 | 215 | 19 | GO:0017111 |
| GeneOntologyMolecularFunction | N-acyltransferase activity | 8.29e-04 | 102 | 215 | 6 | GO:0016410 | |
| GeneOntologyMolecularFunction | acetyltransferase activity | 9.18e-04 | 104 | 215 | 6 | GO:0016407 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 1.06e-03 | 42 | 215 | 4 | GO:0098918 | |
| GeneOntologyMolecularFunction | 14-3-3 protein binding | 1.06e-03 | 42 | 215 | 4 | GO:0071889 | |
| GeneOntologyMolecularFunction | H3K27me3 modified histone binding | 1.13e-03 | 5 | 215 | 2 | GO:0061628 | |
| GeneOntologyMolecularFunction | T cell receptor binding | 1.23e-03 | 20 | 215 | 3 | GO:0042608 | |
| GeneOntologyMolecularFunction | sphingolipid transporter activity | 1.23e-03 | 20 | 215 | 3 | GO:0046624 | |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 1.54e-03 | 78 | 215 | 5 | GO:0008080 | |
| GeneOntologyMolecularFunction | zinc ion binding | HIVEP1 MYT1 CHD4 ACE EHMT2 TRIM55 KDM2B MNAT1 PRIMPOL AGTPBP1 KDM5A MORC4 SUV39H2 TRIM52 ZBBX TLL2 RNF146 TADA2B SMPD1 TRIM13 | 1.59e-03 | 891 | 215 | 20 | GO:0008270 |
| GeneOntologyMolecularFunction | helicase activity | 1.65e-03 | 158 | 215 | 7 | GO:0004386 | |
| GeneOntologyMolecularFunction | phosphatidylcholine flippase activity | 1.68e-03 | 6 | 215 | 2 | GO:0140345 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.76e-03 | 118 | 215 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYH2 MYH3 MYH6 WASF3 ACE MYO3A BRCA2 ARC AFDN AGTPBP1 DNM2 ANK2 CALD1 DNM1L KIF20A MYL12A TUBGCP6 CEP44 DNM3 CTNNA2 AKAP1 MYL12B MX1 | 1.79e-03 | 1099 | 215 | 23 | GO:0008092 |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 1.80e-03 | 206 | 215 | 8 | GO:0140030 | |
| GeneOntologyMolecularFunction | glutamate receptor binding | 1.82e-03 | 81 | 215 | 5 | GO:0035254 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | MYH3 RSF1 DDX42 ATP10B CHD4 SRCAP DNAH6 DNM2 DNM1L RHOT2 MORC4 FANCM ATP10A ATP10D RAD50 KIF20A DNM3 MX1 TDRD12 | 1.88e-03 | 839 | 215 | 19 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | MYH3 RSF1 DDX42 ATP10B CHD4 SRCAP DNAH6 DNM2 DNM1L RHOT2 MORC4 FANCM ATP10A ATP10D RAD50 KIF20A DNM3 MX1 TDRD12 | 1.90e-03 | 840 | 215 | 19 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | MYH3 RSF1 DDX42 ATP10B CHD4 SRCAP DNAH6 DNM2 DNM1L RHOT2 MORC4 FANCM ATP10A ATP10D RAD50 KIF20A DNM3 MX1 TDRD12 | 1.90e-03 | 840 | 215 | 19 | GO:0016818 |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 2.04e-03 | 50 | 215 | 4 | GO:0003755 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase binding | 2.11e-03 | 24 | 215 | 3 | GO:0120283 | |
| GeneOntologyMolecularFunction | protein-RNA adaptor activity | 2.11e-03 | 24 | 215 | 3 | GO:0140517 | |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 2.53e-03 | 53 | 215 | 4 | GO:0016859 | |
| GeneOntologyMolecularFunction | small GTPase binding | RGPD4 RGPD1 RGPD3 AFDN RANBP2 DNM1L PLEKHG2 IPO9 CSE1L PRKACA | 2.60e-03 | 321 | 215 | 10 | GO:0031267 |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 1.29e-06 | 9 | 211 | 4 | GO:0033133 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 2.13e-06 | 10 | 211 | 4 | GO:1903301 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 7.08e-06 | 13 | 211 | 4 | GO:0033131 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 9.83e-06 | 14 | 211 | 4 | GO:1903299 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | RNF168 RSF1 TSPYL2 CHD4 SRCAP BRCA2 EHMT2 PIK3CA SUPT6H KDM2B TAF1 TAF1L PRIMPOL KDM5A RBBP5 HAT1 SUV39H2 RAD50 TGM2 TADA2B TDRD12 | 2.57e-05 | 741 | 211 | 21 | GO:0006338 |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 4.53e-05 | 20 | 211 | 4 | GO:0006607 | |
| GeneOntologyBiologicalProcess | chromatin organization | RNF168 RSF1 TSPYL2 CHD4 SRCAP BRCA2 EHMT2 PIK3CA SUPT6H KDM2B TAF1 TAF1L PRIMPOL KDM5A RBBP5 HAT1 SYCP3 SUV39H2 RAD50 TGM2 RCBTB1 TADA2B TDRD12 | 4.89e-05 | 896 | 211 | 23 | GO:0006325 |
| GeneOntologyBiologicalProcess | meiotic cell cycle | BRCA2 RSPH1 EHMT2 OSGIN2 YTHDF2 SYCP3 FANCM NCAPH RAD50 TUBGCP6 PRKACA PRKACB TDRD12 | 6.87e-05 | 350 | 211 | 13 | GO:0051321 |
| GeneOntologyBiologicalProcess | regulation of gluconeogenesis | 8.79e-05 | 71 | 211 | 6 | GO:0006111 | |
| GeneOntologyBiologicalProcess | nuclear export | 1.26e-04 | 185 | 211 | 9 | GO:0051168 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transmembrane transport | 1.31e-04 | 109 | 211 | 7 | GO:1904427 | |
| GeneOntologyBiologicalProcess | renal water homeostasis | 1.33e-04 | 26 | 211 | 4 | GO:0003091 | |
| GeneOntologyBiologicalProcess | protein localization to organelle | RGPD4 INTU RGPD1 PEX13 F2 RYR2 BRCA2 CCDC47 RGPD3 DLG2 PIBF1 PHIP IL33 RANBP2 ANK2 DNM1L GRIK5 DZIP1 STAM CCDC39 NMD3 IPO9 CSE1L PRKACA AKAP1 | 1.39e-04 | 1091 | 211 | 25 | GO:0033365 |
| GeneOntologyBiologicalProcess | nuclear transport | RGPD4 RGPD1 SUPT6H RGPD3 PHIP IL33 RANBP2 RBM33 NMD3 IPO9 CSE1L PRKACA AKAP1 | 1.48e-04 | 378 | 211 | 13 | GO:0051169 |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | RGPD4 RGPD1 SUPT6H RGPD3 PHIP IL33 RANBP2 RBM33 NMD3 IPO9 CSE1L PRKACA AKAP1 | 1.48e-04 | 378 | 211 | 13 | GO:0006913 |
| GeneOntologyBiologicalProcess | cell junction organization | FILIP1 WASF3 SYNDIG1 CHD4 ACE ARC DLG2 AFDN GNPAT CACNB1 ANK2 PCLO L1CAM PCDHB6 DNM1L CDH19 SHANK2 PRKACA DNM3 CTNNA2 PARD3 CDH11 CX3CR1 | 1.69e-04 | 974 | 211 | 23 | GO:0034330 |
| GeneOntologyBiologicalProcess | protein import into nucleus | 1.87e-04 | 195 | 211 | 9 | GO:0006606 | |
| GeneOntologyBiologicalProcess | replication fork processing | 1.88e-04 | 52 | 211 | 5 | GO:0031297 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transport | 1.91e-04 | 154 | 211 | 8 | GO:0051928 | |
| GeneOntologyBiologicalProcess | regulation of cardiac conduction | 2.07e-04 | 29 | 211 | 4 | GO:1903779 | |
| GeneOntologyBiologicalProcess | import into nucleus | 2.34e-04 | 201 | 211 | 9 | GO:0051170 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | RNF168 RSF1 TSPYL2 CHD4 SRCAP BRCA2 EHMT2 PIK3CA SUPT6H KDM2B TAF1 TAF1L PRIMPOL KDM5A RBBP5 HAT1 SYCP3 SUV39H2 RAD50 TGM2 RCBTB1 TADA2B TDRD12 | 2.44e-04 | 999 | 211 | 23 | GO:0071824 |
| GeneOntologyBiologicalProcess | high-density lipoprotein particle assembly | 2.80e-04 | 13 | 211 | 3 | GO:0034380 | |
| GeneOntologyBiologicalProcess | regulation of SA node cell action potential | 3.10e-04 | 3 | 211 | 2 | GO:0098907 | |
| GeneOntologyBiologicalProcess | cell-cell junction assembly | 3.31e-04 | 167 | 211 | 8 | GO:0007043 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 3.36e-04 | 127 | 211 | 7 | GO:0070252 | |
| GeneOntologyBiologicalProcess | DNA-templated DNA replication maintenance of fidelity | 3.69e-04 | 60 | 211 | 5 | GO:0045005 | |
| GeneOntologyBiologicalProcess | regulation of carbohydrate biosynthetic process | 4.25e-04 | 132 | 211 | 7 | GO:0043255 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion transmembrane transport | 4.26e-04 | 218 | 211 | 9 | GO:1903169 | |
| GeneOntologyBiologicalProcess | multicellular organismal-level water homeostasis | 4.35e-04 | 35 | 211 | 4 | GO:0050891 | |
| GeneOntologyBiologicalProcess | muscle filament sliding | 4.39e-04 | 15 | 211 | 3 | GO:0030049 | |
| GeneOntologyBiologicalProcess | RNA transport | 4.53e-04 | 175 | 211 | 8 | GO:0050658 | |
| GeneOntologyBiologicalProcess | nucleic acid transport | 4.53e-04 | 175 | 211 | 8 | GO:0050657 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 6.71e-07 | 8 | 210 | 4 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 1.98e-06 | 10 | 210 | 4 | GO:0044614 | |
| GeneOntologyCellularComponent | myosin II complex | 7.94e-06 | 28 | 210 | 5 | GO:0016460 | |
| GeneOntologyCellularComponent | annulate lamellae | 9.16e-06 | 14 | 210 | 4 | GO:0005642 | |
| GeneOntologyCellularComponent | supramolecular fiber | MYH2 MYH3 MYH6 TRPC1 RYR2 MYO3A FBN2 RSPH1 TRIM55 DNAH6 DNM2 ANK2 CALD1 KRT85 DNM1L CFAP210 KRT87P PPL KIF20A MYL12A TUBGCP6 SHANK2 SPHKAP DNM3 MYOM2 MYL12B TUBAL3 MX1 | 2.07e-05 | 1179 | 210 | 28 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | MYH2 MYH3 MYH6 TRPC1 RYR2 MYO3A FBN2 RSPH1 TRIM55 DNAH6 DNM2 ANK2 CALD1 KRT85 DNM1L CFAP210 KRT87P PPL KIF20A MYL12A TUBGCP6 SHANK2 SPHKAP DNM3 MYOM2 MYL12B TUBAL3 MX1 | 2.33e-05 | 1187 | 210 | 28 | GO:0099081 |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 2.71e-05 | 18 | 210 | 4 | GO:0044615 | |
| GeneOntologyCellularComponent | myosin complex | 2.77e-05 | 59 | 210 | 6 | GO:0016459 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 4.23e-05 | 20 | 210 | 4 | GO:0042405 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 5.18e-05 | 21 | 210 | 4 | GO:0106068 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | RGPD4 PDE8A RGPD1 SRCAP PIK3CA RGPD3 PLCG2 BANK1 DNM2 RANBP2 ANK2 PCLO DNM1L NOX4 RAD50 TGM2 PRKACA PRKACB DNM3 CLINT1 TRIM13 CX3CR1 MX1 | 6.96e-05 | 934 | 210 | 23 | GO:0048471 |
| GeneOntologyCellularComponent | cytoplasmic region | NEK4 RSPH1 ARC DLG2 SPAG16 DNAH6 AGTPBP1 PCLO CFAP210 CCDC39 GUCY1B1 PRKACA CTNNA2 | 7.62e-05 | 360 | 210 | 13 | GO:0099568 |
| GeneOntologyCellularComponent | myofibril | MYH2 MYH3 MYH6 TRPC1 RYR2 ANK2 CALD1 MYL12A SPHKAP MYOM2 MYL12B | 1.05e-04 | 273 | 210 | 11 | GO:0030016 |
| GeneOntologyCellularComponent | myosin filament | 1.06e-04 | 25 | 210 | 4 | GO:0032982 | |
| GeneOntologyCellularComponent | cAMP-dependent protein kinase complex | 1.14e-04 | 10 | 210 | 3 | GO:0005952 | |
| GeneOntologyCellularComponent | contractile muscle fiber | MYH2 MYH3 MYH6 TRPC1 RYR2 ANK2 CALD1 MYL12A SPHKAP MYOM2 MYL12B | 1.78e-04 | 290 | 210 | 11 | GO:0043292 |
| GeneOntologyCellularComponent | sarcomere | 2.22e-04 | 249 | 210 | 10 | GO:0030017 | |
| GeneOntologyCellularComponent | glutamatergic synapse | FILIP1 WASF3 CHD4 ARC DLG2 DGCR8 DNM2 CACNB1 CALD1 PCLO L1CAM GRIK5 MLF2 ARRB2 SHANK2 GUCY1B1 PRKACA DNM3 SLC17A8 CDH11 | 2.28e-04 | 817 | 210 | 20 | GO:0098978 |
| GeneOntologyCellularComponent | inclusion body | 2.95e-04 | 90 | 210 | 6 | GO:0016234 | |
| GeneOntologyCellularComponent | phospholipid-translocating ATPase complex | 3.35e-04 | 14 | 210 | 3 | GO:1990531 | |
| GeneOntologyCellularComponent | muscle myosin complex | 5.08e-04 | 16 | 210 | 3 | GO:0005859 | |
| GeneOntologyCellularComponent | excitatory synapse | 7.45e-04 | 107 | 210 | 6 | GO:0060076 | |
| GeneOntologyCellularComponent | postsynaptic membrane | SYNDIG1 ARC DLG2 AFDN DNM2 ANK2 GRIK5 ARRB2 SHANK2 DNM3 CTNNA2 AKAP1 | 8.50e-04 | 405 | 210 | 12 | GO:0045211 |
| GeneOntologyCellularComponent | neuromuscular junction | 9.46e-04 | 112 | 210 | 6 | GO:0031594 | |
| GeneOntologyCellularComponent | asymmetric synapse | SYNDIG1 CHD4 ARC DLG2 AFDN DGCR8 DNM2 ANK2 PCLO GRIK5 SHANK2 DNM3 CTNNA2 | 1.12e-03 | 477 | 210 | 13 | GO:0032279 |
| GeneOntologyCellularComponent | cell cortex | MYH2 STOX1 ARC CALD1 GRK4 PCLO MYL12A GUCY1B1 CTNNA2 PARD3 MYL12B | 1.38e-03 | 371 | 210 | 11 | GO:0005938 |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | NEK4 RSPH1 ARC DLG2 SPAG16 DNAH6 AGTPBP1 CFAP210 CCDC39 PRKACA | 1.44e-03 | 317 | 210 | 10 | GO:0032838 |
| GeneOntologyCellularComponent | nuclear speck | EAPP BCLAF1 DDX42 SRSF11 SRSF12 CRNKL1 EHMT2 AFDN SRSF4 SRSF6 DZIP1 PRKACA | 1.45e-03 | 431 | 210 | 12 | GO:0016607 |
| GeneOntologyCellularComponent | postsynapse | FILIP1 WASF3 SYNDIG1 ARC DLG2 AFDN DGCR8 DNM2 CACNB1 ANK2 CALD1 PCLO LAMA2 GRIK5 ARRB2 SHANK2 P2RX5 PRKACA DNM3 CTNNA2 AKAP1 | 1.46e-03 | 1018 | 210 | 21 | GO:0098794 |
| GeneOntologyCellularComponent | presynaptic active zone cytoplasmic component | 1.53e-03 | 23 | 210 | 3 | GO:0098831 | |
| GeneOntologyCellularComponent | transferase complex | RGPD4 RNF168 RGPD1 OTULIN BRCA2 PIK3CA RGPD3 BOD1L1 TAF1 TAF1L MNAT1 PRIMPOL RANBP2 RBBP5 TADA2B PRKACA PRKACB PRKACG WDFY3 PARD3 | 1.75e-03 | 963 | 210 | 20 | GO:1990234 |
| GeneOntologyCellularComponent | postsynaptic specialization | SYNDIG1 ARC DLG2 AFDN DGCR8 DNM2 ANK2 PCLO GRIK5 SHANK2 DNM3 CTNNA2 AKAP1 | 1.80e-03 | 503 | 210 | 13 | GO:0099572 |
| GeneOntologyCellularComponent | A band | 1.84e-03 | 52 | 210 | 4 | GO:0031672 | |
| GeneOntologyCellularComponent | MHC class Ib protein complex | 2.04e-03 | 7 | 210 | 2 | GO:0032398 | |
| GeneOntologyCellularComponent | postsynaptic density | SYNDIG1 ARC DLG2 AFDN DGCR8 DNM2 ANK2 PCLO GRIK5 SHANK2 DNM3 CTNNA2 | 2.11e-03 | 451 | 210 | 12 | GO:0014069 |
| GeneOntologyCellularComponent | MHC protein complex | 2.19e-03 | 26 | 210 | 3 | GO:0042611 | |
| GeneOntologyCellularComponent | condensed nuclear chromosome | 2.25e-03 | 91 | 210 | 5 | GO:0000794 | |
| GeneOntologyCellularComponent | synaptic membrane | SYNDIG1 ARC DLG2 AFDN DNM2 ANK2 L1CAM DNM1L GRIK5 ARRB2 SHANK2 DNM3 CTNNA2 AKAP1 | 2.39e-03 | 583 | 210 | 14 | GO:0097060 |
| GeneOntologyCellularComponent | ciliary base | 2.42e-03 | 56 | 210 | 4 | GO:0097546 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | SYNDIG1 CHD4 ARC DLG2 AFDN DGCR8 DNM2 ANK2 PCLO GRIK5 SHANK2 DNM3 CTNNA2 | 2.52e-03 | 523 | 210 | 13 | GO:0098984 |
| GeneOntologyCellularComponent | extrinsic component of plasma membrane | 2.64e-03 | 137 | 210 | 6 | GO:0019897 | |
| GeneOntologyCellularComponent | pronucleus | 2.72e-03 | 28 | 210 | 3 | GO:0045120 | |
| GeneOntologyCellularComponent | dendritic spine | 3.19e-03 | 242 | 210 | 8 | GO:0043197 | |
| GeneOntologyCellularComponent | nuclear pore | 3.54e-03 | 101 | 210 | 5 | GO:0005643 | |
| GeneOntologyCellularComponent | neuron spine | 3.61e-03 | 247 | 210 | 8 | GO:0044309 | |
| GeneOntologyCellularComponent | MLL1 complex | 4.00e-03 | 32 | 210 | 3 | GO:0071339 | |
| GeneOntologyCellularComponent | catenin complex | 4.00e-03 | 32 | 210 | 3 | GO:0016342 | |
| GeneOntologyCellularComponent | Z disc | 4.27e-03 | 151 | 210 | 6 | GO:0030018 | |
| GeneOntologyCellularComponent | ciliary transition fiber | 4.29e-03 | 10 | 210 | 2 | GO:0097539 | |
| GeneOntologyCellularComponent | MHC class I protein complex | 4.29e-03 | 10 | 210 | 2 | GO:0042612 | |
| GeneOntologyCellularComponent | MLL1/2 complex | 4.37e-03 | 33 | 210 | 3 | GO:0044665 | |
| GeneOntologyCellularComponent | synaptic cleft | 4.37e-03 | 33 | 210 | 3 | GO:0043083 | |
| GeneOntologyCellularComponent | brush border | 4.41e-03 | 152 | 210 | 6 | GO:0005903 | |
| GeneOntologyCellularComponent | contractile actin filament bundle | 4.53e-03 | 107 | 210 | 5 | GO:0097517 | |
| GeneOntologyCellularComponent | stress fiber | 4.53e-03 | 107 | 210 | 5 | GO:0001725 | |
| GeneOntologyCellularComponent | hippocampal mossy fiber to CA3 synapse | 4.63e-03 | 67 | 210 | 4 | GO:0098686 | |
| GeneOntologyCellularComponent | lumenal side of endoplasmic reticulum membrane | 5.16e-03 | 35 | 210 | 3 | GO:0098553 | |
| GeneOntologyCellularComponent | ciliary plasm | 5.17e-03 | 208 | 210 | 7 | GO:0097014 | |
| MousePheno | elevated level of mitotic sister chromatid exchange | 9.27e-07 | 16 | 168 | 5 | MP:0003701 | |
| MousePheno | decreased tumor latency | 1.29e-06 | 30 | 168 | 6 | MP:0010308 | |
| MousePheno | abnormal tumor latency | 2.80e-06 | 34 | 168 | 6 | MP:0010307 | |
| MousePheno | abnormal cell cycle | RGPD4 RNF168 TSPYL2 RGPD1 CNBD2 BRCA2 RGPD3 PRIMPOL GNPAT RANBP2 KDM5A HAT1 SYCP3 FANCM WDFY3 AKAP1 NKAPL TDRD12 | 5.43e-05 | 520 | 168 | 18 | MP:0003077 |
| Domain | Dynamin_central | 2.47e-07 | 6 | 214 | 4 | IPR000375 | |
| Domain | GED | 2.47e-07 | 6 | 214 | 4 | SM00302 | |
| Domain | Dynamin_M | 2.47e-07 | 6 | 214 | 4 | PF01031 | |
| Domain | GED_dom | 2.47e-07 | 6 | 214 | 4 | IPR020850 | |
| Domain | GED | 2.47e-07 | 6 | 214 | 4 | PS51388 | |
| Domain | Dynamin_GTPase_CS | 2.47e-07 | 6 | 214 | 4 | IPR019762 | |
| Domain | GED | 2.47e-07 | 6 | 214 | 4 | PF02212 | |
| Domain | GED | 2.47e-07 | 6 | 214 | 4 | IPR003130 | |
| Domain | G_DYNAMIN_1 | 5.71e-07 | 7 | 214 | 4 | PS00410 | |
| Domain | DYNc | 5.71e-07 | 7 | 214 | 4 | SM00053 | |
| Domain | Ran_BP1 | 7.72e-06 | 12 | 214 | 4 | PF00638 | |
| Domain | RANBD1 | 7.72e-06 | 12 | 214 | 4 | PS50196 | |
| Domain | RanBD | 1.10e-05 | 13 | 214 | 4 | SM00160 | |
| Domain | Ran_bind_dom | 1.10e-05 | 13 | 214 | 4 | IPR000156 | |
| Domain | G_DYNAMIN_dom | 1.53e-05 | 14 | 214 | 4 | IPR030381 | |
| Domain | G_DYNAMIN_2 | 1.53e-05 | 14 | 214 | 4 | PS51718 | |
| Domain | Dynamin_GTPase | 2.07e-05 | 15 | 214 | 4 | IPR001401 | |
| Domain | Dynamin_SF | 2.07e-05 | 15 | 214 | 4 | IPR022812 | |
| Domain | Dynamin_N | 2.07e-05 | 15 | 214 | 4 | PF00350 | |
| Domain | Rab_bind | 5.02e-05 | 7 | 214 | 3 | PF16704 | |
| Domain | GCC2_Rab_bind | 5.02e-05 | 7 | 214 | 3 | IPR032023 | |
| Domain | P-loop_NTPase | MYH2 MYH3 MYH6 DDX42 CHD4 SRCAP MYO3A TRANK1 LRRIQ1 AK5 HELZ DLG2 DNAH6 DNM2 CACNB1 DNM1L RHOT2 FANCM RAD50 KIF20A DNM3 MX1 TDRD12 | 1.17e-04 | 848 | 214 | 23 | IPR027417 |
| Domain | TFIID_sub1_DUF3591 | 1.31e-04 | 2 | 214 | 2 | IPR022591 | |
| Domain | TBP-binding | 1.31e-04 | 2 | 214 | 2 | PF09247 | |
| Domain | DUF3591 | 1.31e-04 | 2 | 214 | 2 | PF12157 | |
| Domain | TAF_II_230-bd | 1.31e-04 | 2 | 214 | 2 | IPR009067 | |
| Domain | - | 1.31e-04 | 2 | 214 | 2 | 1.10.1100.10 | |
| Domain | TAF1_animal | 1.31e-04 | 2 | 214 | 2 | IPR011177 | |
| Domain | Hydrolase_3 | 1.68e-04 | 10 | 214 | 3 | PF08282 | |
| Domain | - | 1.68e-04 | 10 | 214 | 3 | 1.10.220.60 | |
| Domain | Grip | 2.29e-04 | 11 | 214 | 3 | SM00755 | |
| Domain | GRIP | 2.29e-04 | 11 | 214 | 3 | PF01465 | |
| Domain | GRIP_dom | 3.02e-04 | 12 | 214 | 3 | IPR000237 | |
| Domain | GRIP | 3.02e-04 | 12 | 214 | 3 | PS50913 | |
| Domain | EF-hand_11 | 3.89e-04 | 3 | 214 | 2 | PF08976 | |
| Domain | EF_hand_DJBP | 3.89e-04 | 3 | 214 | 2 | IPR015070 | |
| Domain | P_typ_ATPase_c | 4.92e-04 | 14 | 214 | 3 | IPR032630 | |
| Domain | P-type_ATPase_N | 4.92e-04 | 14 | 214 | 3 | IPR032631 | |
| Domain | P-type_ATPase_IV | 4.92e-04 | 14 | 214 | 3 | IPR006539 | |
| Domain | TUDOR | 4.92e-04 | 14 | 214 | 3 | PF00567 | |
| Domain | PhoLip_ATPase_C | 4.92e-04 | 14 | 214 | 3 | PF16212 | |
| Domain | PhoLip_ATPase_N | 4.92e-04 | 14 | 214 | 3 | PF16209 | |
| Domain | Myosin_N | 6.10e-04 | 15 | 214 | 3 | PF02736 | |
| Domain | Myosin_N | 6.10e-04 | 15 | 214 | 3 | IPR004009 | |
| Domain | - | RNF168 RSF1 CHD4 TRIM55 KDM2B MNAT1 PDZRN4 KDM5A PCLO TRIM52 RNF146 ZFYVE26 WDFY3 TRIM13 | 7.02e-04 | 449 | 214 | 14 | 3.30.40.10 |
| Domain | Znf_RING/FYVE/PHD | RNF168 RSF1 CHD4 TRIM55 KDM2B MNAT1 PDZRN4 KDM5A PCLO TRIM52 RNF146 ZFYVE26 WDFY3 TRIM13 | 8.68e-04 | 459 | 214 | 14 | IPR013083 |
| Domain | Myosin_head_motor_dom | 9.12e-04 | 38 | 214 | 4 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 9.12e-04 | 38 | 214 | 4 | PS51456 | |
| Domain | Myosin_head | 9.12e-04 | 38 | 214 | 4 | PF00063 | |
| Domain | MYSc | 9.12e-04 | 38 | 214 | 4 | SM00242 | |
| Domain | Myosin_tail_1 | 1.07e-03 | 18 | 214 | 3 | PF01576 | |
| Domain | Myosin_tail | 1.07e-03 | 18 | 214 | 3 | IPR002928 | |
| Domain | Myosin-like_IQ_dom | 1.26e-03 | 19 | 214 | 3 | IPR027401 | |
| Domain | - | 1.26e-03 | 19 | 214 | 3 | 4.10.270.10 | |
| Domain | Laminin_domII | 1.28e-03 | 5 | 214 | 2 | IPR010307 | |
| Domain | Laminin_aI | 1.28e-03 | 5 | 214 | 2 | IPR009254 | |
| Domain | Laminin_I | 1.28e-03 | 5 | 214 | 2 | PF06008 | |
| Domain | Laminin_II | 1.28e-03 | 5 | 214 | 2 | PF06009 | |
| Domain | IQ | 1.33e-03 | 71 | 214 | 5 | PF00612 | |
| Domain | Znf_FYVE_PHD | 1.55e-03 | 147 | 214 | 7 | IPR011011 | |
| Domain | TPR-contain_dom | 1.74e-03 | 150 | 214 | 7 | IPR013026 | |
| Domain | PDZ | 1.80e-03 | 151 | 214 | 7 | PS50106 | |
| Domain | PDZ | 1.87e-03 | 152 | 214 | 7 | IPR001478 | |
| Domain | MHC_I_a_C | 1.90e-03 | 6 | 214 | 2 | IPR010579 | |
| Domain | MHC_I_C | 1.90e-03 | 6 | 214 | 2 | PF06623 | |
| Domain | TUDOR | 2.22e-03 | 23 | 214 | 3 | PS50304 | |
| Domain | IQ | 2.38e-03 | 81 | 214 | 5 | SM00015 | |
| Domain | Pre-SET | 2.64e-03 | 7 | 214 | 2 | PF05033 | |
| Domain | PreSET | 2.64e-03 | 7 | 214 | 2 | SM00468 | |
| Domain | SaposinB_dom | 2.64e-03 | 7 | 214 | 2 | IPR008139 | |
| Domain | Pre-SET_dom | 2.64e-03 | 7 | 214 | 2 | IPR007728 | |
| Domain | PRE_SET | 2.64e-03 | 7 | 214 | 2 | PS50867 | |
| Domain | - | 2.72e-03 | 207 | 214 | 8 | 1.25.40.10 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | MYH3 MYH6 TRPC1 RYR2 ALDH2 CACNB1 CALD1 MYL12A GUCY1B1 PRKACA MYL12B | 2.97e-06 | 165 | 161 | 11 | MM15026 |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS | 1.44e-05 | 5 | 161 | 3 | M26988 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | MYH3 MYH6 TRPC1 RYR2 ALDH2 CACNB1 CALD1 MYL12A GUCY1B1 PRKACA MYL12B | 2.13e-05 | 203 | 161 | 11 | M5485 |
| Pathway | WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN | 3.35e-05 | 33 | 161 | 5 | M48071 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CX3CR1_GNAI_AC_PKA_SIGNALING_PATHWAY | 3.47e-05 | 17 | 161 | 4 | M47544 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 4.43e-05 | 18 | 161 | 4 | MM1549 | |
| Pathway | REACTOME_SMOOTH_MUSCLE_CONTRACTION | 4.49e-05 | 35 | 161 | 5 | MM15114 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PKA_HOLOENZYME | 4.95e-05 | 7 | 161 | 3 | M47896 | |
| Pathway | KEGG_DILATED_CARDIOMYOPATHY | 7.51e-05 | 90 | 161 | 7 | M835 | |
| Pathway | REACTOME_HDL_ASSEMBLY | 7.85e-05 | 8 | 161 | 3 | M27840 | |
| Pathway | KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS | 1.13e-04 | 96 | 161 | 7 | M16121 | |
| Pathway | REACTOME_ROBO_RECEPTORS_BIND_AKAP5 | 1.17e-04 | 9 | 161 | 3 | M27877 | |
| Pathway | REACTOME_SMOOTH_MUSCLE_CONTRACTION | 1.24e-04 | 43 | 161 | 5 | M1429 | |
| Pathway | KEGG_TIGHT_JUNCTION | 1.35e-04 | 132 | 161 | 8 | M11355 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 1.45e-04 | 70 | 161 | 6 | M12294 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AVP_V2R_PKA_SIGNALING_PATHWAY | 1.65e-04 | 10 | 161 | 3 | M47648 | |
| Pathway | PID_IL3_PATHWAY | 2.01e-04 | 26 | 161 | 4 | M182 | |
| Pathway | BIOCARTA_AGPCR_PATHWAY | 2.26e-04 | 11 | 161 | 3 | M19829 | |
| Pathway | BIOCARTA_NFAT_PATHWAY | 2.81e-04 | 51 | 161 | 5 | M2288 | |
| Pathway | REACTOME_REGULATION_OF_GLYCOLYSIS_BY_FRUCTOSE_2_6_BISPHOSPHATE_METABOLISM | 2.98e-04 | 12 | 161 | 3 | M27950 | |
| Pathway | REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_ADENYLATE_CYCLASE | 2.98e-04 | 12 | 161 | 3 | M27363 | |
| Pathway | KEGG_CHEMOKINE_SIGNALING_PATHWAY | 3.09e-04 | 188 | 161 | 9 | M4844 | |
| Pathway | WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS | 3.56e-04 | 30 | 161 | 4 | M42578 | |
| Pathway | KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION | 3.66e-04 | 116 | 161 | 7 | M2164 | |
| Pathway | REACTOME_DAP12_INTERACTIONS | 3.68e-04 | 54 | 161 | 5 | MM14871 | |
| Pathway | WP_DOPAMINE_METABOLISM | 3.84e-04 | 13 | 161 | 3 | M39622 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 4.22e-04 | 156 | 161 | 8 | M39475 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 5.21e-04 | 202 | 161 | 9 | MM15362 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EP_NE_ADRB_CAMP_SIGNALING_PATHWAY | 6.01e-04 | 15 | 161 | 3 | M47794 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PTH_PTH1R_PKA_SIGNALING_PATHWAY | 6.01e-04 | 15 | 161 | 3 | M47504 | |
| Pathway | WP_CHEMOKINE_SIGNALING | 6.13e-04 | 165 | 161 | 8 | M39400 | |
| Pathway | PID_GMCSF_PATHWAY | 7.26e-04 | 36 | 161 | 4 | M22 | |
| Pathway | REACTOME_RAP1_SIGNALLING | 7.34e-04 | 16 | 161 | 3 | M923 | |
| Pathway | KEGG_MEDICUS_REFERENCE_DRD1_GNAS_AC_PKA_SIGNALING_PATHWAY | 7.34e-04 | 16 | 161 | 3 | M47551 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LHCGR_GNAS_PKA_SIGNALING_PATHWAY | 7.34e-04 | 16 | 161 | 3 | M47645 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FSHR_GNAS_PKA_SIGNALING_PATHWAY | 7.34e-04 | 16 | 161 | 3 | M47650 | |
| Pathway | REACTOME_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING | 8.84e-04 | 17 | 161 | 3 | M26995 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | TRPC1 PIK3CA RPL22L1 VAV2 DNM2 CACNB1 ANK2 L1CAM LAMA2 MYL12A PRKACA PRKACB PRKACG DNM3 MYL12B TUBAL3 | 9.01e-04 | 575 | 161 | 16 | M29853 |
| Pubmed | RGPD4 EFCAB5 MYH2 MYH3 MYH6 INTU BCLAF1 RSF1 DDX42 RGPD1 SRSF11 ATP10B CAGE1 CHD4 CNPY2 STOX1 SRCAP RYR2 CCDC47 RGPD3 DLG2 BOD1L1 ALDH2 DNAH6 RANBP2 STIM2 ANK2 CALD1 KDM5A PCLO CFAP210 NCAPH PPL ESF1 SHANK2 DGKK PRKACA PRKACB MYOM2 | 1.00e-14 | 1442 | 217 | 39 | 35575683 | |
| Pubmed | RGPD4 BCLAF1 RGPD1 CHD4 LRIG2 EHMT2 RGPD3 ARC DLG2 AFDN DNM2 CACNB1 RANBP2 NYAP2 ANK2 KDM5A DNM1L GRIK5 RAD50 SHANK2 SPHKAP STON2 PRKACA PRKACB DNM3 CTNNA2 WDFY3 PARD3 CDH11 | 2.88e-12 | 963 | 217 | 29 | 28671696 | |
| Pubmed | MYH3 HIVEP1 CHD4 EHMT2 SUPT6H TRIM55 TAF1 VAV2 AGTPBP1 DNM2 RANBP2 ANK2 KDM5A RBBP5 LAMA2 LAMA4 DZIP1 MLF2 MYOM2 PARD3 AKAP1 | 7.51e-12 | 497 | 217 | 21 | 23414517 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | HIVEP1 BCLAF1 ZC3H15 RSF1 DDX42 SRSF11 CHD4 SRSF12 CRNKL1 BRCA2 AFDN BOD1L1 DGCR8 TAF1 TAF1L PHIP YTHDF2 RANBP2 SRSF4 SRSF6 CALD1 RBM33 FANCM ESF1 MYL12A STEEP1 CLINT1 MYL12B | 1.29e-11 | 954 | 217 | 28 | 36373674 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | HIVEP1 BCLAF1 ZC3H15 TRPC1 DDX42 CHD4 F2 CRNKL1 CCDC47 SUPT6H ZRANB2 AFDN BOP1 BOD1L1 ALDH2 TDRD6 PHIP RANBP2 SRSF6 NRDC RBBP5 PCLO HAT1 DNM1L NCAPH ESF1 NMD3 RAD50 MYL12A IPO9 CSE1L PRKACA CLINT1 | 8.75e-11 | 1425 | 217 | 33 | 30948266 |
| Pubmed | RSF1 TSPYL2 ZGPAT CRNKL1 EHMT2 SUPT6H ZRANB2 KIAA1958 BOD1L1 PHIP RANBP2 MORC4 NCAPH RAD50 KIF20A MLF2 CSE1L CEP44 STEEP1 | 1.59e-10 | 469 | 217 | 19 | 27634302 | |
| Pubmed | RGPD4 HIVEP1 RGPD1 CHD4 BRCA2 EHMT2 RGPD3 KDM2B KIAA1958 TAF1 RANBP2 KDM5A MORC4 RAD50 ARRB2 CEP44 AKAP1 | 1.43e-09 | 418 | 217 | 17 | 34709266 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | FILIP1 HIVEP1 BCLAF1 CHD4 MYO3A ZRANB2 KDM2B KIAA1958 HELZ AFDN AGTPBP1 DNM2 RANBP2 SRSF6 KDM5A OTUD5 PPL ESF1 RAD50 TUBGCP6 PARD3 AKAP1 | 4.17e-09 | 774 | 217 | 22 | 15302935 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | HIVEP1 RNF168 RSF1 CHD4 SRCAP EHMT2 KDM2B BOP1 BOD1L1 TAF1 PHIP KDM5A RBBP5 PIGK HAT1 SUV39H2 KIF20A TADA2B STEEP1 | 1.12e-08 | 608 | 217 | 19 | 36089195 |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | RGPD4 BCLAF1 RGPD1 CHD4 RGPD3 HELZ BOP1 TAF1 TAF1L YTHDF2 DNM2 RANBP2 RBBP5 DNM1L CSE1L | 1.42e-08 | 370 | 217 | 15 | 22922362 |
| Pubmed | EAPP TEX2 BCLAF1 ZC3H15 DDX42 CNPY2 LRIG2 EHMT2 CCDC47 SUPT6H ZRANB2 BOP1 CCDC97 ALDH2 PIBF1 AGTPBP1 STIM2 COA3 ANK2 SRSF6 DZIP1 ESF1 TUBGCP6 MLF2 PRKACA PRKACB CHID1 TRIM13 PARD3 AKAP1 | 1.62e-08 | 1487 | 217 | 30 | 33957083 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | RGPD4 BCLAF1 DDX42 RGPD1 CHD4 RGPD3 ZRANB2 AFDN BOP1 RANBP2 OTUD5 DNM1L MYL12A MLF2 CSE1L PRKACA PRKACB MYL12B TUBAL3 | 4.62e-08 | 665 | 217 | 19 | 30457570 |
| Pubmed | 5.08e-08 | 7 | 217 | 4 | 9037092 | ||
| Pubmed | 5.08e-08 | 7 | 217 | 4 | 21205196 | ||
| Pubmed | 5.08e-08 | 7 | 217 | 4 | 24403063 | ||
| Pubmed | 5.08e-08 | 7 | 217 | 4 | 23536549 | ||
| Pubmed | 5.08e-08 | 7 | 217 | 4 | 12191015 | ||
| Pubmed | 5.08e-08 | 7 | 217 | 4 | 22821000 | ||
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 5.08e-08 | 7 | 217 | 4 | 11353387 | |
| Pubmed | 5.08e-08 | 7 | 217 | 4 | 30944974 | ||
| Pubmed | 5.08e-08 | 7 | 217 | 4 | 38838144 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 5.08e-08 | 7 | 217 | 4 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 5.08e-08 | 7 | 217 | 4 | 17372272 | |
| Pubmed | 5.08e-08 | 7 | 217 | 4 | 38657106 | ||
| Pubmed | 5.08e-08 | 7 | 217 | 4 | 18949001 | ||
| Pubmed | 5.08e-08 | 7 | 217 | 4 | 25187515 | ||
| Pubmed | 5.08e-08 | 7 | 217 | 4 | 8603673 | ||
| Pubmed | 5.08e-08 | 7 | 217 | 4 | 26632511 | ||
| Pubmed | 5.08e-08 | 7 | 217 | 4 | 23818861 | ||
| Pubmed | 5.08e-08 | 7 | 217 | 4 | 20682751 | ||
| Pubmed | 6.78e-08 | 57 | 217 | 7 | 18022353 | ||
| Pubmed | ZC3H15 ZGPAT CRNKL1 EHMT2 CCDC47 SUPT6H RGPD3 ZRANB2 KDM2B HELZ AFDN BOP1 DGCR8 TAF1L MNAT1 RANBP2 KDM5A RBM33 RBBP5 PIGK CEP164 ESF1 MYL12A SHANK2 TADA2B PRKACA CTNNA2 PARD3 AKAP1 | 6.84e-08 | 1497 | 217 | 29 | 31527615 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | MYH2 MYH3 MYH6 BCLAF1 CHD4 BOP1 TAF1L MNAT1 YTHDF2 DNM2 STIM2 CALD1 RHOT2 ESF1 RAD50 ANKRD36B STON2 PRKACB DNM3 MYL12B NKAPL TUBAL3 | 7.33e-08 | 910 | 217 | 22 | 36736316 |
| Pubmed | A bead-based approach for large-scale identification of in vitro kinase substrates. | BCLAF1 ZC3H15 RSF1 SRSF11 CHD4 SUPT6H ZRANB2 RBM33 NMD3 PRKACB | 8.72e-08 | 163 | 217 | 10 | 22113938 |
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 1.01e-07 | 8 | 217 | 4 | 21670213 | |
| Pubmed | 1.01e-07 | 8 | 217 | 4 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 1.01e-07 | 8 | 217 | 4 | 21310149 | |
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 1.01e-07 | 8 | 217 | 4 | 22262462 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 1.01e-07 | 8 | 217 | 4 | 28745977 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | BCLAF1 ZC3H15 RSF1 DDX42 CHD4 SRCAP HELZ BOD1L1 YTHDF2 DNM2 RANBP2 ANK2 CALD1 DNM1L STAM NCAPH ESF1 RAD50 CEP44 STEEP1 CLINT1 AKAP1 | 1.15e-07 | 934 | 217 | 22 | 33916271 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | HIVEP1 TEX2 SRSF11 NEK4 FNIP1 HELZ AFDN BOD1L1 PIBF1 YTHDF2 ABTB2 STIM2 KDM5A DNM1L TBC1D22B DZIP1 PLEKHG2 IPO9 CLINT1 PARD3 AKAP1 | 1.27e-07 | 861 | 217 | 21 | 36931259 |
| Pubmed | MYH2 HIVEP1 RSF1 RGPD1 ZNF442 RYR2 NEK4 CCDC47 KDM2B DNM2 NYAP2 PIGK RHOT2 MORC4 ESF1 ANKRD36B IPO9 WDFY3 | 1.28e-07 | 638 | 217 | 18 | 31182584 | |
| Pubmed | 1.81e-07 | 9 | 217 | 4 | 28100513 | ||
| Pubmed | 1.81e-07 | 9 | 217 | 4 | 17887960 | ||
| Pubmed | 1.81e-07 | 9 | 217 | 4 | 9733766 | ||
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 1.81e-07 | 9 | 217 | 4 | 18394993 | |
| Pubmed | 1.81e-07 | 9 | 217 | 4 | 11553612 | ||
| Pubmed | 1.81e-07 | 9 | 217 | 4 | 10601307 | ||
| Pubmed | 1.81e-07 | 9 | 217 | 4 | 28877029 | ||
| Pubmed | HIVEP1 RNF168 RYR2 PPP1R26 FBN2 CSRNP2 AFDN PLCG2 DNM2 STIM2 LAMA4 RHOT2 STAM MORC4 PPL TGM2 ARRB2 | 2.20e-07 | 591 | 217 | 17 | 15231748 | |
| Pubmed | The Expression of Dynamin 1, 2, and 3 in Human Hepatocellular Carcinoma and Patient Prognosis. | 2.40e-07 | 3 | 217 | 3 | 32573516 | |
| Pubmed | 2.40e-07 | 3 | 217 | 3 | 19383776 | ||
| Pubmed | 2.40e-07 | 3 | 217 | 3 | 12842892 | ||
| Pubmed | 2.40e-07 | 3 | 217 | 3 | 2342480 | ||
| Pubmed | 2.77e-07 | 23 | 217 | 5 | 9730685 | ||
| Pubmed | 2.77e-07 | 23 | 217 | 5 | 9278385 | ||
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 3.01e-07 | 10 | 217 | 4 | 16332688 | |
| Pubmed | 3.01e-07 | 10 | 217 | 4 | 27160050 | ||
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 3.01e-07 | 10 | 217 | 4 | 8857542 | |
| Pubmed | 3.01e-07 | 10 | 217 | 4 | 21859863 | ||
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 3.74e-07 | 146 | 217 | 9 | 23892456 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RSF1 CHD4 SRCAP ZGPAT CRNKL1 CCDC47 AFDN BOP1 RPL22L1 PLCG2 PHIP YTHDF2 RANBP2 SRSF6 RHOT2 NCAPH ESF1 NMD3 RAD50 KIF20A TGM2 IPO9 ARRB2 CSE1L WDFY3 PARD3 | 4.04e-07 | 1353 | 217 | 26 | 29467282 |
| Pubmed | RNF168 EAPP BCLAF1 RSF1 DDX42 CHD4 CRNKL1 EHMT2 SUPT6H BOP1 BOD1L1 TAF1 MNAT1 RANBP2 RBBP5 HAT1 DNM1L NCAPH ESF1 RAD50 CSE1L STEEP1 | 4.61e-07 | 1014 | 217 | 22 | 32416067 | |
| Pubmed | 4.70e-07 | 11 | 217 | 4 | 17069463 | ||
| Pubmed | 4.70e-07 | 11 | 217 | 4 | 34110283 | ||
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 4.70e-07 | 11 | 217 | 4 | 35771867 | |
| Pubmed | BCLAF1 CHD4 RYR2 LRIG2 EHMT2 ZRANB2 AFDN DGCR8 STIM2 DNM1L TBC1D22B NCAPH PPL ESF1 KIF20A AP4E1 CLINT1 PARD3 AKAP1 | 5.01e-07 | 777 | 217 | 19 | 35844135 | |
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | TMPRSS13 SRSF11 RYR2 ZGPAT TDRD6 YTHDF2 CALD1 RBM33 RAD50 MYOM2 | 5.07e-07 | 197 | 217 | 10 | 20811636 |
| Pubmed | BCLAF1 RSF1 CHD4 SRSF12 SUPT6H ZRANB2 BOD1L1 CCDC97 SRSF4 RBBP5 MYL12A | 5.85e-07 | 251 | 217 | 11 | 31076518 | |
| Pubmed | 7.02e-07 | 12 | 217 | 4 | 10830164 | ||
| Pubmed | BCLAF1 SRSF11 CHD4 SRCAP CRNKL1 ZRANB2 BOD1L1 CCDC97 MNAT1 CALD1 RBM33 DNM1L ESF1 MYL12A STEEP1 | 7.99e-07 | 506 | 217 | 15 | 30890647 | |
| Pubmed | 9.54e-07 | 4 | 217 | 3 | 16155788 | ||
| Pubmed | 9.54e-07 | 4 | 217 | 3 | 18385332 | ||
| Pubmed | A rational nomenclature for serine/arginine-rich protein splicing factors (SR proteins). | 1.01e-06 | 13 | 217 | 4 | 20516191 | |
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 1.01e-06 | 13 | 217 | 4 | 31427429 | |
| Pubmed | 1.18e-06 | 86 | 217 | 7 | 37253089 | ||
| Pubmed | 1.91e-06 | 15 | 217 | 4 | 14697343 | ||
| Pubmed | 2.37e-06 | 5 | 217 | 3 | 12972513 | ||
| Pubmed | 2.37e-06 | 5 | 217 | 3 | 9540970 | ||
| Pubmed | HIV-1 Tat binds to SH3 domains: cellular and viral outcome of Tat/Grb2 interaction. | 2.37e-06 | 5 | 217 | 3 | 21745501 | |
| Pubmed | 2.37e-06 | 5 | 217 | 3 | 19483721 | ||
| Pubmed | PKA-mediated stabilization of FoxH1 negatively regulates ERalpha activity. | 2.37e-06 | 5 | 217 | 3 | 19711044 | |
| Pubmed | BCLAF1 ZC3H15 CCDC47 AFDN BOD1L1 YTHDF2 RANBP2 STIM2 ANK2 CALD1 ICE2 TMEM51 DNM1L STAM CSE1L CLINT1 PARD3 | 2.60e-06 | 708 | 217 | 17 | 39231216 | |
| Pubmed | 3.06e-06 | 99 | 217 | 7 | 27746211 | ||
| Pubmed | RGPD4 TEX2 BCLAF1 RGPD1 RYR2 RGPD3 HELZ DLG2 AFDN CACNB1 RANBP2 STIM2 NYAP2 ANK2 PCLO MYL12A CSE1L SHANK2 GUCY1B1 SPHKAP CTNNA2 MYL12B | 3.08e-06 | 1139 | 217 | 22 | 36417873 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | DDX42 SRSF11 CHD4 OTULIN DNM2 RANBP2 SRSF4 SRSF6 RBBP5 DNM1L NCAPH RAD50 IPO9 CSE1L CLINT1 | 4.42e-06 | 582 | 217 | 15 | 20467437 |
| Pubmed | HLA-DRB5 DDX42 HLA-F PEX13 CHD4 CCDC47 HELZ GNPAT RANBP2 PIGK DNM1L RHOT2 NCAPH NMD3 RAD50 TUBGCP6 MLF2 IPO9 CSE1L CHID1 CLINT1 AKAP1 | 4.60e-06 | 1168 | 217 | 22 | 19946888 | |
| Pubmed | 4.73e-06 | 6 | 217 | 3 | 27251629 | ||
| Pubmed | Architectural DNA-binding properties of the spermatidal transition proteins 1 and 2. | 4.73e-06 | 6 | 217 | 3 | 9837753 | |
| Pubmed | 4.73e-06 | 6 | 217 | 3 | 25947375 | ||
| Pubmed | Ser276 phosphorylation of NF-kB p65 by MSK1 controls SCF expression in inflammation. | 4.73e-06 | 6 | 217 | 3 | 19197368 | |
| Pubmed | Unproductive splicing of SR genes associated with highly conserved and ultraconserved DNA elements. | 4.73e-06 | 6 | 217 | 3 | 17361132 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | MYH2 HIVEP1 CHD4 SUPT6H ZRANB2 BOP1 RPL22L1 NRDC OTUD5 KRT85 HAT1 NMD3 RAD50 IPO9 CSE1L TADA2B PRKACA CLINT1 AKAP1 MYL12B | 5.73e-06 | 1005 | 217 | 20 | 19615732 |
| Pubmed | INTU ZC3H15 RSF1 TSPYL2 CHD4 SRCAP ZNF469 FBN2 EHMT2 HELZ TAF1 PHIP AGTPBP1 KDM5A RHOT2 RAD50 KIF20A TUBGCP6 TADA2B WDFY3 PARD3 | 7.77e-06 | 1116 | 217 | 21 | 31753913 | |
| Pubmed | PEX13 BRCA2 EHMT2 PLCG2 DNM2 ANK2 SUV39H2 LEPR SHANK2 DNM3 CDH11 | 7.94e-06 | 329 | 217 | 11 | 17474147 | |
| Pubmed | 7.98e-06 | 268 | 217 | 10 | 33640491 | ||
| Pubmed | 8.23e-06 | 7 | 217 | 3 | 16407073 | ||
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 8.23e-06 | 7 | 217 | 3 | 15710750 | |
| Pubmed | 8.23e-06 | 7 | 217 | 3 | 21126233 | ||
| Pubmed | 8.23e-06 | 7 | 217 | 3 | 16819597 | ||
| Interaction | RGPD3 interactions | 6.25e-07 | 47 | 215 | 7 | int:RGPD3 | |
| Interaction | SMC5 interactions | HIVEP1 BCLAF1 ZC3H15 RSF1 DDX42 SRSF11 CHD4 SRSF12 CRNKL1 BRCA2 AFDN BOD1L1 DGCR8 TAF1 TAF1L PHIP YTHDF2 RANBP2 SRSF4 SRSF6 CALD1 RBM33 FANCM ESF1 RAD50 MYL12A STEEP1 CLINT1 MYL12B | 9.75e-07 | 1000 | 215 | 29 | int:SMC5 |
| Interaction | RGPD4 interactions | 3.00e-06 | 22 | 215 | 5 | int:RGPD4 | |
| Interaction | H3C3 interactions | HIVEP1 RNF168 RSF1 CHD4 SRCAP EHMT2 SUPT6H KDM2B BOP1 BOD1L1 TAF1 PHIP KDM5A RBBP5 PIGK HAT1 KIF20A STEEP1 | 6.54e-06 | 495 | 215 | 18 | int:H3C3 |
| Interaction | CEP19 interactions | ZC3H15 TSPYL2 PEX13 ZGPAT KIAA1958 PIBF1 YTHDF2 NCAPH IPO9 PARD3 | 7.42e-06 | 157 | 215 | 10 | int:CEP19 |
| Interaction | H2BC9 interactions | MYH2 HIVEP1 TRPC1 SRSF11 CHD4 PGM3 ZNF469 DNAH6 PCLO LAMA2 ESF1 IPO9 DGKK PRKACA PRKACB WDFY3 | 2.55e-05 | 446 | 215 | 16 | int:H2BC9 |
| Interaction | TERF2IP interactions | HIVEP1 RSF1 DDX42 SRSF11 SRCAP ZGPAT BRCA2 SUPT6H ZRANB2 KDM2B BOD1L1 DGCR8 TAF1 MNAT1 RAD50 TADA2B STEEP1 WDFY3 | 2.81e-05 | 552 | 215 | 18 | int:TERF2IP |
| Interaction | OTUD7A interactions | 3.50e-05 | 58 | 215 | 6 | int:OTUD7A | |
| Cytoband | 1p31 | 2.73e-06 | 21 | 217 | 4 | 1p31 | |
| Cytoband | 17q23.3 | 1.21e-05 | 30 | 217 | 4 | 17q23.3 | |
| GeneFamily | RNA binding motif containing|Serine and arginine rich splicing factors | 1.87e-06 | 12 | 145 | 4 | 737 | |
| GeneFamily | Myosin heavy chains | 2.14e-04 | 15 | 145 | 3 | 1098 | |
| GeneFamily | ATPase phospholipid transporting | 2.14e-04 | 15 | 145 | 3 | 1210 | |
| GeneFamily | PDZ domain containing | 2.27e-04 | 152 | 145 | 7 | 1220 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 3.29e-04 | 115 | 145 | 6 | 769 | |
| GeneFamily | EF-hand domain containing | 1.96e-03 | 219 | 145 | 7 | 863 | |
| GeneFamily | Transglutaminases | 2.22e-03 | 9 | 145 | 2 | 773 | |
| GeneFamily | Zinc fingers CCCH-type | 2.74e-03 | 35 | 145 | 3 | 73 | |
| GeneFamily | Tudor domain containing | 3.22e-03 | 37 | 145 | 3 | 780 | |
| GeneFamily | Ankyrin repeat domain containing | 3.42e-03 | 242 | 145 | 7 | 403 | |
| GeneFamily | Laminin subunits | 4.00e-03 | 12 | 145 | 2 | 626 | |
| GeneFamily | Gla domain containing | 4.70e-03 | 13 | 145 | 2 | 1250 | |
| GeneFamily | CD molecules|Type II classical cadherins | 4.70e-03 | 13 | 145 | 2 | 1186 | |
| GeneFamily | Histocompatibility complex|C1-set domain containing | 5.26e-03 | 44 | 145 | 3 | 588 | |
| GeneFamily | Myosin light chains|EF-hand domain containing | 5.46e-03 | 14 | 145 | 2 | 657 | |
| GeneFamily | PHD finger proteins | 5.95e-03 | 90 | 145 | 4 | 88 | |
| GeneFamily | Ring finger proteins | 6.80e-03 | 275 | 145 | 7 | 58 | |
| GeneFamily | OTU domain containing | 8.03e-03 | 17 | 145 | 2 | 669 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 8.03e-03 | 17 | 145 | 2 | 486 | |
| Coexpression | GSE26290_CTRL_VS_AKT_INHIBITOR_TREATED_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_UP | 5.89e-06 | 196 | 217 | 10 | M8135 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | BCLAF1 RSF1 SRSF11 PIK3CA CCDC47 ALDH2 PIBF1 MNAT1 AGTPBP1 CALD1 ICE2 DNM1L NOX4 DZIP1 CDH19 ESF1 NMD3 RAD50 | 9.95e-06 | 656 | 217 | 18 | M18979 |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 1.68e-05 | 221 | 217 | 10 | M39222 | |
| Coexpression | GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_UP | 2.03e-05 | 180 | 217 | 9 | M8127 | |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_GRANULOCYTE_AGEING | 2.77e-05 | 43 | 217 | 5 | MM3857 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | HIVEP1 PDE8A TRPC1 WASF3 DDX42 NEK4 BRCA2 HELZ PIBF1 MNAT1 PHIP RANBP2 KDM5A HAT1 STAM CSE1L PRKACB CLINT1 WDFY3 PARD3 | 3.23e-05 | 856 | 217 | 20 | M4500 |
| Coexpression | HEVNER_CORTEX_COMMITTED_TO_SUBCEREBRAL_PROJECTION_NEURON_FATE | 4.53e-05 | 9 | 217 | 3 | MM429 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | MYT1 RYR2 SRSF12 KDM2B DLG2 BOD1L1 VAV2 AGTPBP1 PDZRN4 STIM2 ANK2 RBM33 PCLO L1CAM NOX4 RHOT2 ANKRD36B SHANK2 MEGF6 RNF146 PRKACB DNM3 CTNNA2 | 4.98e-05 | 1106 | 217 | 23 | M39071 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | PDE8A TEX2 TRPC1 WASF3 TRANK1 BRCA2 FNIP1 HELZ DGCR8 TAF1 PLCG2 OSGIN2 KDM5A ICE2 GRK4 HAT1 SYCP3 ATP10A SUV39H2 ESF1 NMD3 RAD50 DGKK TDRD12 | 2.54e-06 | 820 | 212 | 24 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | HIVEP1 RNF168 EAPP SRSF11 NEK4 CSRNP2 SUPT6H PRIMPOL KDM5A ICE2 DNM1L PLEKHG2 FANCM NCAPH ESF1 RAD50 AP4E1 CLINT1 WDFY3 | 4.17e-06 | 564 | 212 | 19 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | RNF168 EAPP CHD4 SRCAP CRNKL1 SUPT6H HELZ BOD1L1 TAF1 SRSF4 KDM5A RBBP5 PCLO DNM1L ESF1 RAD50 TADA2B WDFY3 | 3.17e-05 | 595 | 212 | 18 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_500 | TEX2 WASF3 BRCA2 RSPH1 DGCR8 PLCG2 HAT1 SYCP3 ATP10A SUV39H2 RAD50 TRIM13 KCTD18 TDRD12 | 3.71e-05 | 387 | 212 | 14 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_500 |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_top-relative-expression-ranked_1000 | TEX2 WASF3 BRCA2 RSPH1 HELZ DGCR8 TAF1 PLCG2 OSGIN2 PRIMPOL HAT1 SYCP3 ATP10A SUV39H2 NMD3 RAD50 KIF20A ARRB2 TRIM13 AKAP1 TDRD12 | 5.40e-05 | 799 | 212 | 21 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_1000 |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | FILIP1 MYH6 SYNDIG1 RYR2 TRIM55 ANK2 LAMA2 SPHKAP MYOM2 GPA33 | 2.18e-08 | 181 | 217 | 10 | 719eb532453ab7cd7893726885bc75d74a10b21e |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.68e-08 | 185 | 217 | 10 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.60e-08 | 200 | 217 | 10 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-07 | 165 | 217 | 9 | 0edd56e8d14eaeced9882dd9206ea93e8f402e8d | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-07 | 165 | 217 | 9 | fa3aadfff6fb1e7f142db333c60c2cba02b17e6c | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.16e-07 | 176 | 217 | 9 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 3.15e-07 | 184 | 217 | 9 | d2bf0135eb56bb410997dccea39c5ede88a0617f | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.15e-07 | 184 | 217 | 9 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | PBMC-Convalescent-Hematopoietic-Platelet-Platelet-plt_4|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.30e-07 | 185 | 217 | 9 | af078a6c4a3e0b54b7d8ab7b30dcd06053ebfd28 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 4.13e-07 | 190 | 217 | 9 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.13e-07 | 190 | 217 | 9 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 4.31e-07 | 191 | 217 | 9 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 5.13e-07 | 195 | 217 | 9 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | PSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.59e-07 | 197 | 217 | 9 | 6865f4831eb23794fb88a8649d48d497bbae3f44 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | BCLAF1 RSF1 LRRIQ1 BOD1L1 CFAP210 CCDC39 RAD50 ANKRD36B CLINT1 | 6.08e-07 | 199 | 217 | 9 | 61b1ed2db71b96157b92b7535d1955a4033098da |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.34e-07 | 200 | 217 | 9 | ad3fdcef895400f929f2ae12ff9bd85fd46adb3a | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.34e-07 | 200 | 217 | 9 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.34e-07 | 200 | 217 | 9 | 74e74123ea7bf38d337a3a0248a6a51437c6ab42 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal|6m / Sample Type, Dataset, Time_group, and Cell type. | 6.34e-07 | 200 | 217 | 9 | 13ec8afea86e4a10599c924871ba4e325b0a8013 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 7.91e-07 | 151 | 217 | 8 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.54e-06 | 165 | 217 | 8 | 0c714e852f912b5749de4cb0895406673979b2e6 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.54e-06 | 165 | 217 | 8 | 82530f96aaefe28a13bad0474bbad043f127a86c | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.93e-06 | 170 | 217 | 8 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.20e-06 | 173 | 217 | 8 | c3762655caa79ac4879876f470d32578a3c93b01 | |
| ToppCell | Posterior_cortex-Macroglia-OLIGODENDROCYTE|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.57e-06 | 124 | 217 | 7 | 9f169fa17be1842a6bd83778ff30465a740edd5f | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 3.47e-06 | 184 | 217 | 8 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 3.62e-06 | 185 | 217 | 8 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | PBMC-Convalescent-Hematopoietic-Platelet-Platelet-plt_4|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.62e-06 | 185 | 217 | 8 | 709236097cbfc254796fcc69b5f5178b73dad9bd | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_proliferating_SCP1_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.76e-06 | 186 | 217 | 8 | 3113c85d0ac5fc46532c19b1bb71f34b985e1276 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.92e-06 | 187 | 217 | 8 | 48bfdb3504c3fefe5db3abac4b790c369680ab4e | |
| ToppCell | P15-Epithelial-airway_epithelial_cell-club_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.92e-06 | 187 | 217 | 8 | a70aaae32426e9ddb1cbfbd0e0db24ccc96b9f40 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.92e-06 | 187 | 217 | 8 | 958402fcc78f4c7a7d13d659d776f3817137975f | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 4.07e-06 | 188 | 217 | 8 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | multiciliated|World / shred by cell class for bronchial biopsy | 4.07e-06 | 188 | 217 | 8 | 6833c1f0f265ef5448fa65033550ed7efc2f8d7b | |
| ToppCell | P15-Epithelial-airway_epithelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.07e-06 | 188 | 217 | 8 | e3e71c0f2e374330620cb4d27638953ffa9f5298 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 4.24e-06 | 189 | 217 | 8 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.40e-06 | 190 | 217 | 8 | 9ce7df056bfb24d70db4c3c4a2c57d89115de877 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor | 4.40e-06 | 190 | 217 | 8 | 7dcca3469f3a3b70db0420cb94f7765f39492f06 | |
| ToppCell | facs-Lung-nan-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.40e-06 | 190 | 217 | 8 | fe844559b95832845d2e8d3ab4b57e3d558bc372 | |
| ToppCell | facs-Lung-nan-3m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.40e-06 | 190 | 217 | 8 | e243b5fbb17b9ec3cc90bbe970c1d30b0fd1c2e1 | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.40e-06 | 190 | 217 | 8 | 833481ace2800354712e2ce709d5cdfd0aed3d42 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 4.40e-06 | 190 | 217 | 8 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 4.58e-06 | 191 | 217 | 8 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.58e-06 | 191 | 217 | 8 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | multiciliated|World / shred by cell class for turbinate | 4.76e-06 | 192 | 217 | 8 | 0f89ea0deb651ca11531c51ee94e0233608d22ea | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.76e-06 | 192 | 217 | 8 | 1b6cac8156e608061e1405e36e18d185b6fa8f6f | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 4.94e-06 | 193 | 217 | 8 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 4.94e-06 | 193 | 217 | 8 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.94e-06 | 193 | 217 | 8 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | ASK440-Epithelial-Ciliated|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.94e-06 | 193 | 217 | 8 | a0baa8be6f590b2031fede22be588715ae458e93 | |
| ToppCell | ASK440-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.13e-06 | 194 | 217 | 8 | c84a7fa94fb06e08aae04db56c8c313b0afde1d7 | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.13e-06 | 194 | 217 | 8 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.13e-06 | 194 | 217 | 8 | b4ce60c06568123008b1081d644733cb91c28f51 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 5.13e-06 | 194 | 217 | 8 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 5.13e-06 | 194 | 217 | 8 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.13e-06 | 194 | 217 | 8 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 5.13e-06 | 194 | 217 | 8 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.13e-06 | 194 | 217 | 8 | 7a7ddccfe72a4a0dc4d1a5c809988f0069f9f1a3 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.23e-06 | 138 | 217 | 7 | 611fe0fb284e12678f9c47a0bdbfc367a93c52b3 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 5.33e-06 | 195 | 217 | 8 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | normal_Lung-Epithelial_cells-Ciliated|Epithelial_cells / Location, Cell class and cell subclass | 5.33e-06 | 195 | 217 | 8 | a3e2999fdd4c3575add6e28ecfd1d6606a61f992 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 5.33e-06 | 195 | 217 | 8 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.33e-06 | 195 | 217 | 8 | cd6cfe3ef150a4a4575e04fc8a8213cdceefa1c4 | |
| ToppCell | NS-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.33e-06 | 195 | 217 | 8 | 34e37cff4849696ca4ba5dd8fd2cf98fed8bc912 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 5.33e-06 | 195 | 217 | 8 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.33e-06 | 195 | 217 | 8 | 9651ee03738226ee10e901f8b9ec6a417eb9c301 | |
| ToppCell | BL-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.33e-06 | 195 | 217 | 8 | 07a6bcef6af93ed87df455dee624037cb75e011a | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.33e-06 | 195 | 217 | 8 | 2d19148df56e99f66b596af2d7f9d0f10f9a9087 | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 5.33e-06 | 195 | 217 | 8 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.33e-06 | 195 | 217 | 8 | 43f0c257e4bb5c627afbdfc695c1199c672842d3 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Ciliated|Control_saline / Treatment groups by lineage, cell group, cell type | 5.33e-06 | 195 | 217 | 8 | 60067b5359174f0d1a8b5748bfc0690762e9e740 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.53e-06 | 196 | 217 | 8 | 1522958a92e0126326a9f0d9fb1c5b5c50b001ea | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.53e-06 | 196 | 217 | 8 | 1c8294014713684b50885e638668f2ce75f357f0 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ciliated-diff|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.53e-06 | 196 | 217 | 8 | 9a91a6e5f93ce3bb5a0fc63677553f4c2df95c43 | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 5.53e-06 | 196 | 217 | 8 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.75e-06 | 197 | 217 | 8 | 71fea4aa6ce96c7693fa94792d08770622873850 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.75e-06 | 197 | 217 | 8 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.75e-06 | 197 | 217 | 8 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.75e-06 | 197 | 217 | 8 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | control-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.75e-06 | 197 | 217 | 8 | e453d085182364ca347cbcc9dc995c62c3353016 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 5.75e-06 | 197 | 217 | 8 | 1a1bee8da6e04b65935c40373eaee4d6c046d9a1 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.75e-06 | 197 | 217 | 8 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.75e-06 | 197 | 217 | 8 | d83c61d2b5742e463122e1a98c7197a5b5b3d41b | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 5.75e-06 | 197 | 217 | 8 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | control-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.75e-06 | 197 | 217 | 8 | d4e963c1f82996371bf3d63578ee9fce8e00c5a8 | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 5.96e-06 | 198 | 217 | 8 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 6.19e-06 | 199 | 217 | 8 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | proximal-Epithelial-Ciliated|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.19e-06 | 199 | 217 | 8 | 9700f06e51ddca85e482b4f9bd4a79bfcd3cfb76 | |
| ToppCell | distal-3-Epithelial-Ciliated|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.19e-06 | 199 | 217 | 8 | 7e5f29f4ec1fea92f2c0064eea151d2d474ef904 | |
| ToppCell | distal-Epithelial-Ciliated-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.19e-06 | 199 | 217 | 8 | 6ce0df4a6f4d9353919e26ffab97c9ec89911da6 | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 6.19e-06 | 199 | 217 | 8 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | distal-Epithelial-Ciliated|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.19e-06 | 199 | 217 | 8 | 18ca031cfe702afb9bf94e03c0f3680c38e7599e | |
| ToppCell | proximal-3-Epithelial-Ciliated|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.19e-06 | 199 | 217 | 8 | 1188afad6fd5f01f9aeba225f611f38b237dd2c9 | |
| ToppCell | proximal-Epithelial-Ciliated-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.19e-06 | 199 | 217 | 8 | 2e8ace105c4e2405baa06d953e52888b54e2d055 | |
| ToppCell | Biopsy_IPF-Epithelial-Ciliated|Biopsy_IPF / Sample group, Lineage and Cell type | 6.42e-06 | 200 | 217 | 8 | bb8c99156e547a8eb6599b6b6bc3c66bf77af7f8 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte|LPS_only / Treatment groups by lineage, cell group, cell type | 6.42e-06 | 200 | 217 | 8 | 8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.42e-06 | 200 | 217 | 8 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2|Control_saline / Treatment groups by lineage, cell group, cell type | 6.42e-06 | 200 | 217 | 8 | bc8949eb34482aca166c4602ff6ab876cb4c2c3c | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.42e-06 | 200 | 217 | 8 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.28e-06 | 148 | 217 | 7 | d61123f0c811287843d066b932b4a9ff09c07c5b | |
| Drug | NSC339663 | MYH2 MYH3 MYH6 MYO3A PIK3CA ARC AFDN RHOT2 PPL MYL12A ARRB2 SHANK2 MYL12B TUBAL3 | 1.29e-07 | 250 | 216 | 14 | CID000003892 |
| Drug | formycin triphosphate | 5.10e-07 | 51 | 216 | 7 | CID000122274 | |
| Drug | AC1L1KMJ | TRPC1 F2 PIK3CA PLCG2 DNM2 ANK2 LAMA2 LAMA4 DNM1L AQP1 MYL12A CSE1L PRKACA PRKACB PRKACG DNM3 MYL12B TUBAL3 | 7.44e-07 | 476 | 216 | 18 | CID000030956 |
| Drug | purealin | 1.25e-06 | 58 | 216 | 7 | CID006419303 | |
| Drug | isoproterenol | MYH2 MYH3 MYH6 PDE8A F2 ACE RYR2 MYO3A AFDN ANK2 GRK4 NOX4 MYL12A P2RX5 GUCY1B1 PRKACA PRKACB PRKACG SMPD1 MYL12B TUBAL3 | 1.76e-06 | 669 | 216 | 21 | CID000003779 |
| Drug | nifedipine | MYH2 MYH3 MYH6 TRPC1 F2 ACE RYR2 MYO3A CACNB1 GRIK5 MYL12A PRKACA PRKACB PRKACG SMPD1 MYL12B | 2.44e-06 | 415 | 216 | 16 | CID000004485 |
| Drug | fast white | 2.68e-06 | 42 | 216 | 6 | CID000024008 | |
| Drug | carbachol | MYH2 MYH3 MYH6 TRPC1 RYR2 MYO3A PROZ PIK3CA PLCD1 PLCG2 CACNB1 CALD1 LAMA4 PLEKHG2 MYL12A GUCY1B1 PRKACA PRKACB PRKACG SMPD1 MYL12B | 2.74e-06 | 688 | 216 | 21 | CID000002551 |
| Drug | Methyldopa (L,-) [555-30-6]; Up 200; 19uM; MCF7; HT_HG-U133A | CAPN9 TRPC1 ATP10B ZNF442 ARC AFDN PDZRN4 CALD1 TGM2 CDH11 MX1 | 3.04e-06 | 197 | 216 | 11 | 3234_UP |
| Drug | GTP[S] | TRPC1 F2 AFDN PLCD1 PLCG2 DNM2 CACNB1 CALD1 HAT1 DNM1L MYL12A TGM2 ARRB2 PRKACA PRKACB PRKACG DNM3 MYL12B MX1 | 3.99e-06 | 591 | 216 | 19 | CID000001764 |
| Drug | AC1NRBPQ | 6.61e-06 | 137 | 216 | 9 | CID005288569 | |
| Drug | AC1L1IZ2 | MYH2 MYH3 MYH6 RYR2 MYO3A AK5 AFDN MYL12A PRKACA PRKACB PRKACG MYL12B TUBAL3 | 7.31e-06 | 304 | 216 | 13 | CID000004795 |
| Drug | eye gene | MYH2 MYH3 MYH6 TRPC1 ACE MYO3A PROZ AFDN PLCD1 PLCG2 CALD1 MYL12A GUCY1B1 MYL12B | 1.26e-05 | 369 | 216 | 14 | CID000004782 |
| Drug | Arg-pro | 1.31e-05 | 82 | 216 | 7 | CID000151003 | |
| Drug | milrinone | 1.38e-05 | 150 | 216 | 9 | CID000004197 | |
| Drug | AC1L9JXQ | 1.40e-05 | 33 | 216 | 5 | CID000446658 | |
| Drug | B0683 | 1.62e-05 | 117 | 216 | 8 | CID006398969 | |
| Drug | creatine | 1.65e-05 | 193 | 216 | 10 | CID000000586 | |
| Drug | Fillalbin [4540-25-4]; Up 200; 13.8uM; MCF7; HT_HG-U133A | ATP10B TRANK1 AFDN CACNB1 CALD1 TBC1D22B AQP1 PRKACA WDFY3 AKAP1 | 1.81e-05 | 195 | 216 | 10 | 4172_UP |
| Drug | Sulfaphenazole [526-08-9]; Down 200; 12.8uM; PC3; HT_HG-U133A | 1.89e-05 | 196 | 216 | 10 | 1794_DN | |
| Drug | Piperidolate hydrochloride [129-77-1]; Down 200; 11.2uM; MCF7; HT_HG-U133A | SRCAP ZNF442 PLCG2 SUV39H2 SIDT2 IPO9 SHANK2 STEEP1 WDFY3 PARD3 | 1.89e-05 | 196 | 216 | 10 | 6772_DN |
| Drug | SM-2 | 1.93e-05 | 87 | 216 | 7 | CID000486033 | |
| Drug | Ricinine [524-40-3]; Up 200; 24.4uM; MCF7; HT_HG-U133A | 1.97e-05 | 197 | 216 | 10 | 6067_UP | |
| Drug | 3-Acetylcoumarin [3949-36-8]; Up 200; 21.2uM; MCF7; HT_HG-U133A | MYH6 SYNDIG1 RYR2 TBC1D22B GRIK5 TGM2 MEGF6 GUCY1B1 PRKACA CDH11 | 1.97e-05 | 197 | 216 | 10 | 3382_UP |
| Drug | Methoxy-6-harmalan [3589-73-9]; Up 200; 18.6uM; HL60; HG-U133A | 2.06e-05 | 198 | 216 | 10 | 1743_UP | |
| Drug | Todralazine hydrochloride [3778-76-5]; Up 200; 14.8uM; HL60; HT_HG-U133A | MYT1 TSPYL2 SRCAP RYR2 DGCR8 CACNB1 GRIK5 CEP164 SIDT2 CSE1L | 2.06e-05 | 198 | 216 | 10 | 1841_UP |
| Drug | Butamben [94-25-7]; Up 200; 20.6uM; MCF7; HT_HG-U133A | 2.15e-05 | 199 | 216 | 10 | 6093_UP | |
| Drug | Dizocilpine maleate [77086-22-7]; Up 200; 11.8uM; MCF7; HT_HG-U133A | CAPN9 TSPYL2 SYNDIG1 PLCD1 DGCR8 TAF1 AQP1 SIDT2 MEGF6 CDH11 | 2.15e-05 | 199 | 216 | 10 | 2232_UP |
| Drug | Amphotericin B [1397-89-3]; Down 200; 4.4uM; PC3; HT_HG-U133A | ZNF442 ALDH2 SH3TC2 SIDT2 ARRB2 CSE1L SHANK2 P2RX5 WDFY3 AKAP1 | 2.25e-05 | 200 | 216 | 10 | 6303_DN |
| Drug | estradiol, USP; Up 200; 0.01uM; MCF7; HT_HG-U133A | ATP10B SYNDIG1 TRANK1 ARC AFDN DGCR8 PCLO ATP10A PRKACG AKAP1 | 2.25e-05 | 200 | 216 | 10 | 5601_UP |
| Drug | 3-Acetylcoumarin [3949-36-8]; Up 200; 21.2uM; HL60; HT_HG-U133A | 2.25e-05 | 200 | 216 | 10 | 3044_UP | |
| Drug | Mitoxantrone | MYH6 PDE8A HLA-DRB5 RYR2 CSRNP2 ALDH2 ANK2 LAMA2 GUCY1B1 RCBTB1 MYOM2 | 2.57e-05 | 247 | 216 | 11 | ctd:D008942 |
| Drug | NSC611747 | MYH2 MYH3 MYH6 BCLAF1 TRPC1 F2 MYO3A MYL12A PRKACA PRKACB PRKACG AKAP1 MYL12B | 3.42e-05 | 352 | 216 | 13 | CID000002534 |
| Drug | S-(-)-Etomoxir | 4.76e-05 | 100 | 216 | 7 | CID000060765 | |
| Drug | pyrophosphate | MYH2 MYH3 MYH6 EAPP PGM3 MYO3A PIK3CA AFDN PLCD1 TAF1 PLCG2 ALDH2 MNAT1 MYL12A GUCY1B1 PRKACA WDFY3 MYL12B | 5.62e-05 | 654 | 216 | 18 | CID000001023 |
| Drug | 9-beta-D-arabinofuranosylguanine | PDE8A LRIG2 PLCD1 PLCG2 VAV2 DNM2 DNM1L RHOT2 PPL KIF20A MYL12A TGM2 GUCY1B1 RCBTB1 PRKACA PRKACB PRKACG DNM3 MYL12B TUBAL3 MX1 | 5.68e-05 | 843 | 216 | 21 | CID000000765 |
| Drug | myo-inositol | TEX2 TRPC1 F2 RYR2 TRPM5 PIK3CA PLCD1 PLCG2 DNM2 CACNB1 DNM1L LCT ARRB2 CSE1L P2RX5 PRKACA PRKACB PRKACG DNM3 CLINT1 | 9.83e-05 | 811 | 216 | 20 | CID000000892 |
| Drug | caffeine | MYH6 PDE8A TRPC1 RYR2 NEK4 PLCD1 PLCG2 PHIP CACNB1 GRIK5 SERPINA6 P2RX5 PRKACA PRKACB PRKACG SMPD1 | 9.94e-05 | 562 | 216 | 16 | CID000002519 |
| Drug | Starlicide | 9.96e-05 | 49 | 216 | 5 | CID000007255 | |
| Drug | Finasteride [98319-26-7]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 1.03e-04 | 194 | 216 | 9 | 3641_UP | |
| Drug | Chloropyramine hydrochloride [6170-42-9]; Down 200; 12.2uM; PC3; HT_HG-U133A | 1.03e-04 | 194 | 216 | 9 | 4589_DN | |
| Drug | Ethaverine hydrochloride [985-13-7]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 1.11e-04 | 196 | 216 | 9 | 3375_UP | |
| Drug | Tolbutamide [64-77-7]; Down 200; 14.8uM; PC3; HT_HG-U133A | 1.11e-04 | 196 | 216 | 9 | 4540_DN | |
| Drug | Pentetic acid [67-43-6]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 1.11e-04 | 196 | 216 | 9 | 5629_UP | |
| Drug | D-myo-inositol-1,4,5-triphosphate | TRPC1 F2 ACE RYR2 PLCD1 PLCG2 CACNB1 STIM2 ANK2 HAT1 MYL12A PRKACA PRKACB PRKACG SMPD1 MYL12B | 1.12e-04 | 568 | 216 | 16 | CID000000806 |
| Drug | Gibberellic acid [77-06-5]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 1.16e-04 | 197 | 216 | 9 | 4818_UP | |
| Drug | Tiletamine hydrochloride; Up 200; 15.4uM; MCF7; HT_HG-U133A | 1.20e-04 | 198 | 216 | 9 | 6013_UP | |
| Drug | (1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Up 200; 11.8uM; PC3; HT_HG-U133A | 1.20e-04 | 198 | 216 | 9 | 3810_UP | |
| Drug | Nisoxetine hydrochloride [57754-86-6]; Up 200; 13uM; MCF7; HT_HG-U133A | 1.20e-04 | 198 | 216 | 9 | 6496_UP | |
| Drug | Griseofulvin [126-07-8]; Up 200; 11.2uM; HL60; HT_HG-U133A | 1.20e-04 | 198 | 216 | 9 | 2332_UP | |
| Drug | blebbistatin | 1.22e-04 | 116 | 216 | 7 | CID003476986 | |
| Drug | NDMA | 1.33e-04 | 52 | 216 | 5 | CID000008749 | |
| Disease | progressive familial intrahepatic cholestasis (implicated_via_orthology) | 3.61e-07 | 3 | 211 | 3 | DOID:0070221 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 3.26e-06 | 15 | 211 | 4 | DOID:0050646 (implicated_via_orthology) | |
| Disease | centronuclear myopathy 1 (implicated_via_orthology) | 3.57e-06 | 5 | 211 | 3 | DOID:0111223 (implicated_via_orthology) | |
| Disease | microcytic anemia (implicated_via_orthology) | 3.57e-06 | 5 | 211 | 3 | DOID:11252 (implicated_via_orthology) | |
| Disease | Charcot-Marie-Tooth disease dominant intermediate B (implicated_via_orthology) | 3.57e-06 | 5 | 211 | 3 | DOID:0110197 (implicated_via_orthology) | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 4.17e-05 | 10 | 211 | 3 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 4.17e-05 | 10 | 211 | 3 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 4.17e-05 | 10 | 211 | 3 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 4.17e-05 | 10 | 211 | 3 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 4.17e-05 | 10 | 211 | 3 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 4.17e-05 | 10 | 211 | 3 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 4.17e-05 | 10 | 211 | 3 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 4.17e-05 | 10 | 211 | 3 | DOID:0080326 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | CPAMD8 ZNF442 FBN2 PIK3CA ALDH2 PHIP AGTPBP1 PDZRN4 CACNB1 ANK2 SRSF6 HAT1 STAM TGM2 MLF2 CSE1L | 5.02e-05 | 702 | 211 | 16 | C0009402 |
| Disease | autosomal recessive polycystic kidney disease (biomarker_via_orthology) | 5.70e-05 | 11 | 211 | 3 | DOID:0110861 (biomarker_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 7.56e-05 | 12 | 211 | 3 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 7.56e-05 | 12 | 211 | 3 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 9.78e-05 | 13 | 211 | 3 | DOID:397 (implicated_via_orthology) | |
| Disease | developmental and epileptic encephalopathy (implicated_via_orthology) | 9.78e-05 | 13 | 211 | 3 | DOID:0112202 (implicated_via_orthology) | |
| Disease | Bipolar Disorder | ACE NEK4 TRANK1 BRCA2 DLG2 ALDH2 PCLO GRIK5 TGM2 ARRB2 SHANK2 TLL2 | 1.81e-04 | 477 | 211 | 12 | C0005586 |
| Disease | Renal Insufficiency | 2.28e-04 | 17 | 211 | 3 | C1565489 | |
| Disease | hereditary spastic paraplegia (implicated_via_orthology) | 2.52e-04 | 43 | 211 | 4 | DOID:2476 (implicated_via_orthology) | |
| Disease | cortical surface area measurement | EFCAB5 FILIP1 CPAMD8 INTU PDE8A MYT1 RGPD1 STOX1 ZNF469 FBN2 LRRIQ1 MNAT1 BANK1 PDZRN4 NYAP2 RBBP5 LAMA2 MLF2 IFTAP MEGF6 PARD3 CDH11 | 2.75e-04 | 1345 | 211 | 22 | EFO_0010736 |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 2.77e-04 | 80 | 211 | 5 | DOID:12930 (implicated_via_orthology) | |
| Disease | myopathy (implicated_via_orthology) | 3.86e-04 | 48 | 211 | 4 | DOID:423 (implicated_via_orthology) | |
| Disease | sick sinus syndrome (is_implicated_in) | 5.02e-04 | 5 | 211 | 2 | DOID:13884 (is_implicated_in) | |
| Disease | Sterility, Reproductive | 5.02e-04 | 5 | 211 | 2 | C4074771 | |
| Disease | Subfertility | 5.02e-04 | 5 | 211 | 2 | C0729353 | |
| Disease | Infertility | 5.02e-04 | 5 | 211 | 2 | C0021359 | |
| Disease | Kidney Failure | 5.02e-04 | 22 | 211 | 3 | C0035078 | |
| Disease | Schizophrenia | CHD4 F2 ACE PIK3CA ARC KDM2B DLG2 DGCR8 GNPAT LAMA2 GRIK5 TGM2 RCBTB1 STON2 CTNNA2 NKAPL | 6.58e-04 | 883 | 211 | 16 | C0036341 |
| Disease | pre-eclampsia (is_implicated_in) | 7.38e-04 | 25 | 211 | 3 | DOID:10591 (is_implicated_in) | |
| Disease | Fanconi Anemia | 7.38e-04 | 25 | 211 | 3 | C0015625 | |
| Disease | breast cancer (implicated_via_orthology) | 7.38e-04 | 25 | 211 | 3 | DOID:1612 (implicated_via_orthology) | |
| Disease | Acute Confusional Senile Dementia | 7.40e-04 | 99 | 211 | 5 | C0546126 | |
| Disease | Alzheimer's Disease, Focal Onset | 7.40e-04 | 99 | 211 | 5 | C0750900 | |
| Disease | Alzheimer Disease, Early Onset | 7.40e-04 | 99 | 211 | 5 | C0750901 | |
| Disease | Presenile dementia | 7.40e-04 | 99 | 211 | 5 | C0011265 | |
| Disease | Alzheimer Disease, Late Onset | 7.40e-04 | 99 | 211 | 5 | C0494463 | |
| Disease | Alzheimer's disease (implicated_via_orthology) | 7.46e-04 | 57 | 211 | 4 | DOID:10652 (implicated_via_orthology) | |
| Disease | Familial Alzheimer Disease (FAD) | 7.74e-04 | 100 | 211 | 5 | C0276496 | |
| Disease | Alzheimer's Disease | 8.10e-04 | 101 | 211 | 5 | C0002395 | |
| Disease | Calcium channel blocker use measurement | 8.94e-04 | 213 | 211 | 7 | EFO_0009930 | |
| Disease | alcohol use disorder measurement | 9.19e-04 | 214 | 211 | 7 | EFO_0009458 | |
| Disease | level of oxylipin in blood plasma | 1.04e-03 | 7 | 211 | 2 | OBA_2050338 | |
| Disease | nephrosis (implicated_via_orthology) | 1.04e-03 | 7 | 211 | 2 | DOID:2527 (implicated_via_orthology) | |
| Disease | osteoarthritis | 1.14e-03 | 222 | 211 | 7 | MONDO_0005178 | |
| Disease | Breast Cancer, Familial | 1.27e-03 | 30 | 211 | 3 | C0346153 | |
| Disease | pseudouridine measurement | 1.39e-03 | 8 | 211 | 2 | EFO_0021126 | |
| Disease | sleep duration, circadian rhythm, excessive daytime sleepiness measurement, insomnia measurement | 1.39e-03 | 8 | 211 | 2 | EFO_0004354, EFO_0005271, EFO_0007875, EFO_0007876 | |
| Disease | vital capacity | FILIP1 MYH2 MYT1 RYR2 ZGPAT LRRIQ1 BOP1 ALDH2 PIBF1 SH3TC2 NYAP2 PCLO LAMA2 LCT LEPR CSE1L DNM3 CTNNA2 PARD3 | 1.49e-03 | 1236 | 211 | 19 | EFO_0004312 |
| Disease | Non-alcoholic Fatty Liver Disease | 1.61e-03 | 70 | 211 | 4 | C0400966 | |
| Disease | Nonalcoholic Steatohepatitis | 1.61e-03 | 70 | 211 | 4 | C3241937 | |
| Disease | clear cell renal cell carcinoma (is_marker_for) | 1.68e-03 | 33 | 211 | 3 | DOID:4467 (is_marker_for) | |
| Disease | mitral valve prolapse (is_implicated_in) | 1.77e-03 | 9 | 211 | 2 | DOID:988 (is_implicated_in) | |
| Disease | response to alcohol | 2.08e-03 | 75 | 211 | 4 | EFO_0005526 | |
| Disease | intellectual disability (implicated_via_orthology) | 2.08e-03 | 75 | 211 | 4 | DOID:1059 (implicated_via_orthology) | |
| Disease | alopecia areata (is_marker_for) | 2.21e-03 | 10 | 211 | 2 | DOID:986 (is_marker_for) | |
| Disease | VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder) | 2.21e-03 | 10 | 211 | 2 | C1631597 | |
| Disease | aspartate aminotransferase measurement | ZGPAT CCDC97 ALDH2 PHIP BANK1 ABTB2 NYAP2 RBBP5 NOX4 STAM SERPINA6 LCT LEPR IPO9 CTNNA2 | 2.28e-03 | 904 | 211 | 15 | EFO_0004736 |
| Disease | venous thromboembolism, factor VII measurement | 2.53e-03 | 38 | 211 | 3 | EFO_0004286, EFO_0004619 | |
| Disease | obstructive sleep apnea (is_implicated_in) | 2.68e-03 | 11 | 211 | 2 | DOID:0050848 (is_implicated_in) | |
| Disease | alcohol use disorder (implicated_via_orthology) | 2.88e-03 | 195 | 211 | 6 | DOID:1574 (implicated_via_orthology) | |
| Disease | congestive heart failure (implicated_via_orthology) | 3.15e-03 | 41 | 211 | 3 | DOID:6000 (implicated_via_orthology) | |
| Disease | liver disease (is_implicated_in) | 3.20e-03 | 12 | 211 | 2 | DOID:409 (is_implicated_in) | |
| Disease | collagen disease (implicated_via_orthology) | 3.20e-03 | 12 | 211 | 2 | DOID:854 (implicated_via_orthology) | |
| Disease | Alcoholic Intoxication, Chronic | 3.28e-03 | 268 | 211 | 7 | C0001973 | |
| Disease | diffuse plaque measurement | PDE8A PPP1R26 FBN2 EHMT2 AGTPBP1 ANK2 NRDC RBBP5 GRIK5 SERPINA6 SHANK2 IFTAP GPA33 | 3.34e-03 | 758 | 211 | 13 | EFO_0010699 |
| Disease | Kidney Diseases | 3.71e-03 | 88 | 211 | 4 | C0022658 | |
| Disease | alcohol and nicotine codependence | 3.77e-03 | 13 | 211 | 2 | EFO_0004776 | |
| Disease | Takayasu arteritis | 4.32e-03 | 148 | 211 | 5 | EFO_1001857 | |
| Disease | glycodeoxycholate measurement | 4.38e-03 | 14 | 211 | 2 | EFO_0010493 | |
| Disease | atrial fibrillation (is_implicated_in) | 4.38e-03 | 14 | 211 | 2 | DOID:0060224 (is_implicated_in) | |
| Disease | Hereditary Breast and Ovarian Cancer Syndrome | 4.38e-03 | 14 | 211 | 2 | C0677776 | |
| Disease | brain edema (biomarker_via_orthology) | 5.03e-03 | 15 | 211 | 2 | DOID:4724 (biomarker_via_orthology) | |
| Disease | vitamin K-dependent protein C measurement | 5.03e-03 | 15 | 211 | 2 | EFO_0008318 | |
| Disease | diffusing capacity of the lung for carbon monoxide | 5.06e-03 | 96 | 211 | 4 | EFO_0009369 | |
| Disease | birth weight, pelvic organ prolapse | 5.21e-03 | 49 | 211 | 3 | EFO_0004344, EFO_0004710 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 5.21e-03 | 49 | 211 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | Hereditary Diffuse Gastric Cancer | 5.32e-03 | 293 | 211 | 7 | C1708349 | |
| Disease | unipolar depression, bipolar disorder | 5.38e-03 | 156 | 211 | 5 | EFO_0003761, MONDO_0004985 | |
| Disease | Schizoaffective disorder-bipolar type | 5.72e-03 | 16 | 211 | 2 | EFO_0009965 | |
| Disease | myopia (is_implicated_in) | 5.72e-03 | 16 | 211 | 2 | DOID:11830 (is_implicated_in) | |
| Disease | dual specificity mitogen-activated protein kinase kinase 2 measurement | 5.72e-03 | 16 | 211 | 2 | EFO_0008112 | |
| Disease | Pre-Eclampsia | 5.72e-03 | 16 | 211 | 2 | C0032914 | |
| Disease | Stomach Neoplasms | 5.72e-03 | 297 | 211 | 7 | C0038356 | |
| Disease | Malignant neoplasm of stomach | 6.03e-03 | 300 | 211 | 7 | C0024623 | |
| Disease | sexual dimorphism measurement | FILIP1 RGPD1 CNBD2 ZGPAT TRANK1 AK5 FNIP1 MNAT1 PHIP BANK1 NYAP2 RHOT2 GSDMC CEP164 SCUBE3 DNM3 | 6.18e-03 | 1106 | 211 | 16 | EFO_0021796 |
| Disease | Weight Gain | 6.26e-03 | 102 | 211 | 4 | C0043094 | |
| Disease | proprotein convertase subtilisin/kexin type 7 measurement | 6.45e-03 | 17 | 211 | 2 | EFO_0008270 | |
| Disease | renal fibrosis (implicated_via_orthology) | 6.45e-03 | 17 | 211 | 2 | DOID:0050855 (implicated_via_orthology) | |
| Disease | glomerulonephritis (implicated_via_orthology) | 6.45e-03 | 17 | 211 | 2 | DOID:2921 (implicated_via_orthology) | |
| Disease | systemic scleroderma (is_marker_for) | 6.49e-03 | 53 | 211 | 3 | DOID:418 (is_marker_for) | |
| Disease | Acute Cerebrovascular Accidents | 6.84e-03 | 54 | 211 | 3 | C0751956 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DVKEYERENVDTFEA | 591 | Q13523 | |
| EQENDYEEDIASFST | 411 | Q8NDB2 | |
| EYAEDSSDEEDIRNT | 121 | Q14137 | |
| FTAKFVAYNEEEEEE | 1726 | P55196 | |
| QDLEVDLYDEDTDRD | 371 | A0FGR9 | |
| ASYEETNEVEIRYVD | 781 | Q92667 | |
| EDVVRVYAEADSQES | 501 | O95394 | |
| FERENEYESTLCEDA | 71 | Q8TC20 | |
| EEEDYEEELTDNRNR | 551 | Q02641 | |
| YTDFDEIRQEIENET | 101 | O00429 | |
| EAEASKFVEEYDRTS | 646 | P12821 | |
| HVDEFEVFYDEETLS | 461 | P17405 | |
| DIDVENVEVDDYFFL | 161 | Q9H175 | |
| RDLYQTLYVDADEEE | 306 | Q7LC44 | |
| DDDEQRTFQDEYEIS | 231 | Q9BYG8 | |
| EEYDLDADDINSRVE | 251 | P29972 | |
| NDEFIEFNEVSEDYA | 296 | Q9C0F1 | |
| YFDSDSEDEDRAVQV | 106 | Q56P03 | |
| ESVTENFEYDDLAEA | 6 | P49238 | |
| EADVREDDSYLFDLD | 1076 | Q96KQ7 | |
| AEDYASEAENRVIFD | 221 | Q8N2N9 | |
| YAVLDELEDFTDNLE | 196 | Q8WYQ5 | |
| FLEEVDYSAESNDEL | 1181 | Q9UPW5 | |
| FDTNYATDDDIVFED | 376 | P32121 | |
| QRLARYQEADSEEEE | 456 | O60312 | |
| FFLSNDLDLYDEETD | 396 | O94823 | |
| ARRLESYQEAVSEDE | 466 | Q9P241 | |
| SYQEAVSEDEDFIDT | 471 | Q9P241 | |
| EGFDDETEDQQLRLY | 476 | Q9UPM8 | |
| DERASLQDELREYEE | 36 | Q9UFE4 | |
| YVDQERENISTEFRE | 616 | Q9UFE4 | |
| DRFTDEEVDELYREA | 131 | P19105 | |
| FSAAVRYDAEDLEEF | 476 | Q8NDN9 | |
| ESDVTQEEERDGQYF | 2296 | P49792 | |
| TETEFPDEDEETRLY | 776 | Q96EV2 | |
| DADRTEDFEYEEVEL | 391 | Q6ZMN7 | |
| EDFEYEEVELCRVSS | 396 | Q6ZMN7 | |
| EYIEIRSDADENVSA | 1161 | Q92878 | |
| VEYVDDTQFLRFDSD | 46 | P30511 | |
| YVDDTQFVRFDSDDA | 51 | P01893 | |
| YRNSIEFFEEISDEA | 3471 | Q01484 | |
| LDFQDSQESLSDEEY | 1061 | Q5KSL6 | |
| SNFDDYEEEEIRVSI | 326 | P17612 | |
| AFSSQYEEALQDEEE | 231 | Q9BZ81 | |
| SLREYNDFLEEVEEI | 91 | P51948 | |
| YNQEEDLRFDSDVGE | 61 | Q30154 | |
| YSEIESKVREATNDD | 21 | Q14677 | |
| EEEDDYRQEEQRSTG | 296 | Q99795 | |
| DLSETAELIEEYEVF | 111 | Q9Y6K8 | |
| YEEEVALRATAENEF | 211 | P78386 | |
| IDVIDHDDFRYETQA | 266 | Q86SR1 | |
| EQDETYLEDSFCVDE | 1596 | Q8IYD8 | |
| IVEYDDNDFAEFEDV | 31 | Q96A33 | |
| DIVARDEEERYFDEE | 316 | Q96F63 | |
| RANFDEENAYFEDEE | 66 | Q86XP3 | |
| FTDFDEVRLEIEAET | 91 | Q9UQ16 | |
| FQAYLASSSEDEEEI | 536 | Q9H501 | |
| FYEEEERAEADVIRQ | 306 | Q53EV4 | |
| IEDEYVTDYTREIQE | 2141 | Q9Y6V0 | |
| YETDAIQRTEELEEA | 1381 | Q9UKX2 | |
| TEREVSDLTRQYEDE | 1126 | O60437 | |
| AARISEEYFSQTDEE | 741 | O60658 | |
| EQVYDLLEEEDEFDR | 796 | P51957 | |
| ESENLFDDSLRVDYF | 761 | P09848 | |
| EAEGTEVTYEDESQR | 966 | P48357 | |
| YEEEVALRATAENEF | 26 | A6NCN2 | |
| ETFGEYRSLESDNEE | 1171 | P32004 | |
| QAARQEELDDDFSYA | 721 | Q96RT7 | |
| QLTFTISYDLEEEEE | 601 | P24043 | |
| FYEDLDRFEENGTQE | 191 | Q02153 | |
| SNYVEDISTADFEEL | 821 | P16885 | |
| FRKEDDDQSEAVYEE | 256 | Q9P242 | |
| FTDFDEVRQEIEAET | 91 | P50570 | |
| EDEVETTYSRFQDLI | 1566 | P42694 | |
| DVEVDYRSYEVTVEN | 116 | Q92643 | |
| EETDSDEDIRETYGY | 1341 | P29375 | |
| VSVTQEAEREEFFDE | 71 | P42336 | |
| ESDEEYREIDLEDFI | 1426 | Q96JM4 | |
| YREIDLEDFIFDEAA | 1431 | Q96JM4 | |
| EDFVELNAARYRDED | 136 | Q9NPH5 | |
| ENVEYEERESEFDIE | 341 | Q15291 | |
| EEEDEELSNFAYLLA | 1011 | Q86Y26 | |
| SQTDSLEDEEIEAFY | 191 | P51178 | |
| SSQEEDEDYDFEDRV | 21 | Q9ULD6 | |
| DEQTRIALQEEADYF | 81 | Q6PI47 | |
| YSFEEQDVSLALDVD | 596 | Q9H094 | |
| DELFTNEAEEYSLYE | 216 | Q96BN8 | |
| VSRLYRDQDDDDIQD | 201 | Q9Y236 | |
| ESDVTQEEERDGQYF | 1321 | A6NKT7 | |
| YSDSDDELTVEQRRQ | 481 | Q8NFC6 | |
| TYEEEIFLSSELQEE | 706 | A4FU69 | |
| VESDAEAEAVREVYE | 501 | Q9BZJ0 | |
| SYIDFEIEQEETERT | 681 | Q9BZJ0 | |
| TDSEFDLTNIEEYAE | 6 | Q9C0G6 | |
| DQSITFALEDESYEI | 131 | O95760 | |
| NLYLDFDDDVTELET | 391 | Q659A1 | |
| EVQLFSLDEEFDYDN | 171 | Q86VG3 | |
| EQLEESFQELVEDYR | 396 | O14929 | |
| SNFDDYEEEDIRVSI | 326 | P22694 | |
| SNFDDYEEEELRISI | 326 | P22612 | |
| DRQRYDENEDLSDVE | 46 | Q8NHM5 | |
| LEDDSDFEQEDYDVR | 636 | P26232 | |
| DFEQEDYDVRSRTSV | 641 | P26232 | |
| EEDHFSEEQYLAAVR | 591 | O15228 | |
| SKDSENYFETEAVEI | 2216 | P51587 | |
| DEYFNDDSIETRTID | 836 | Q8TF40 | |
| DTEETEDYRQFRKSV | 401 | Q9NYF8 | |
| QVFQELEDYDVSDSF | 636 | Q8IZJ3 | |
| VEEYEDELIEFFSRE | 141 | Q9Y2B0 | |
| FEEEDVRENIITYDD | 651 | P55287 | |
| FYSISQERFLDELED | 76 | Q9Y2R0 | |
| VEDEDDDTFSYTVRI | 386 | Q96P70 | |
| EIEYEFEEITLERGN | 91 | Q15700 | |
| YVFRTETETCEDINE | 841 | P35556 | |
| DIFELQRDSQYETTD | 66 | Q16478 | |
| IEFLDAVAEYEVADD | 81 | P32298 | |
| AVAEYEVADDEDRSD | 86 | P32298 | |
| VLRYADEELQLDFDD | 636 | O14815 | |
| EDIDHVFSEEDYRTL | 161 | Q14839 | |
| YRFDEFDEAIDEAIE | 1021 | Q96T23 | |
| YRIESDEEEDFENVG | 1341 | Q96T23 | |
| YDEDYEQLVEDIVRD | 916 | Q8IX30 | |
| TEDVLADDRDDYDFL | 1406 | Q92736 | |
| FDLASTREENFYVDE | 211 | P08185 | |
| SEDFRENIFQYDDEG | 631 | Q9H159 | |
| TYDDFRNVLDSEDEI | 156 | Q9BWS9 | |
| YFLEATEDAELAEAA | 521 | Q96LW4 | |
| EERQDYINLDESEAA | 176 | Q15773 | |
| YINLDESEAAAFDDE | 181 | Q15773 | |
| NSEDEYEAAAARIEA | 176 | Q96G74 | |
| QDEDVEDRRRTYSFE | 1166 | Q8TEW0 | |
| SDVTQEEERDGQYFE | 1306 | P0DJD0 | |
| FFTQRELVDEEADEA | 436 | Q16363 | |
| DFEEIQSYDVDVEAT | 306 | Q9Y5E3 | |
| YEEVRGLEDSSQEAE | 351 | Q93086 | |
| DEEATGTIQEDYLRE | 111 | O14950 | |
| YELDTDQRTCIDVDD | 361 | O75095 | |
| ESDVTQEEERDGQYF | 1321 | Q7Z3J3 | |
| LEEESEVDESRNDYE | 221 | Q2M3C7 | |
| EEEIEAREVADSYAQ | 166 | Q9H5V9 | |
| EFDDLRDADDAVYEL | 41 | Q08170 | |
| KDAEFERTYVDEVNS | 31 | Q8NBJ9 | |
| DLSDFYVQLIEDEAE | 1316 | O60522 | |
| VFLSEYVEEDVENFD | 321 | Q9NU19 | |
| SVEDQFTRAYDFETE | 16 | Q8IZU3 | |
| LSYDVEEEEEFQELE | 146 | Q9H7V2 | |
| DDYEIEYDQDAETLI | 171 | Q86TJ2 | |
| TEDEYDQLEQKFRTE | 656 | Q7Z7B0 | |
| VDYSEAEQTDEELRE | 56 | Q8IXI1 | |
| RSTEDAVDYSDINEV | 101 | Q8IZX4 | |
| VRSTEDAVDYSDINE | 101 | P21675 | |
| SDINEVAEDESRRYQ | 111 | P21675 | |
| EARLCAVEEDTFEVY | 171 | Q587J7 | |
| DTDQYDILVSDFDTE | 236 | Q8TE76 | |
| QYDERTSRELEDAFS | 116 | Q9NTX7 | |
| FSEEDEFVAYLEASR | 501 | Q8TF17 | |
| YETDAIQRTEELEEA | 1376 | P11055 | |
| VARAEYDFAAVSEEE | 276 | Q92968 | |
| DDSVDRDIEEAIQEY | 126 | Q5T8A7 | |
| EICVYEEAREVFENE | 61 | P22891 | |
| DLAALERDYEEVAQS | 431 | A6NHL2 | |
| ADVLREESREYDQEE | 271 | Q8WYR4 | |
| EFEDSRDADDAVYEL | 41 | Q13247 | |
| VEYLLARDEEQSEAD | 551 | Q6ZRS2 | |
| DCDLLREQYEEETEA | 1341 | P13533 | |
| SSEEEQEDDDLIRAY | 681 | Q86YF9 | |
| VQFEDVRDAEDALYN | 56 | Q8WXF0 | |
| YLEEEITVDVRDEFS | 566 | Q8WXE9 | |
| ALYQDALVEEDVDSF | 1561 | Q9UPX8 | |
| FSSIREEEYNEELVT | 771 | Q8N961 | |
| EKSESRQERYEIEET | 151 | Q05682 | |
| FVQEDIYDEFVERSV | 326 | P05091 | |
| DFEYEESLRTSQPEE | 251 | Q9UPV0 | |
| FQDYAREVIELESET | 471 | Q0VFZ6 | |
| EETEFLVVDREDFFA | 206 | Q96M20 | |
| EIDFEDDIDFDVYFR | 471 | Q15003 | |
| TQFIEEESLSDYDRD | 66 | Q9NQ89 | |
| YAEERQSAEDYEKEE | 101 | Q5M9Q1 | |
| NSEEFEDLDEIVARY | 1401 | Q7KZ85 | |
| DAVYLDSEEERQEYV | 146 | P21980 | |
| ELSLVEVEFRNDYEE | 246 | P48995 | |
| DVYREEEILEAYDED | 146 | Q96A61 | |
| IREIDFYREDEDEEE | 321 | Q9BYV6 | |
| AADEEAFEDNSEEYI | 356 | P55060 | |
| AFEDNSEEYIRRDLE | 361 | P55060 | |
| LSEDENRSYVEIVED | 401 | Q96BR9 | |
| IINSNYTDEEDDYDI | 401 | Q9BYE2 | |
| YAVEDIFSEISDIDE | 431 | Q9H2G4 | |
| IEDAYAQERDAFESL | 131 | O60858 | |
| EELLQNYVDDFSEES | 1156 | Q8IZQ1 | |
| LRYFQISQDEDESES | 106 | Q6P5R6 | |
| YDFEQEGSEELDTVI | 316 | Q9NZQ8 | |
| AFYNEDDSEEEQRQL | 1776 | Q8WWQ0 | |
| VTRDYDEEEQGYDSE | 421 | Q05519 | |
| YRNEEEEEAIYFSAE | 571 | Q9P246 | |
| ESLTSFYQEEIQERD | 631 | O95235 | |
| YLEEDDISENDDLRQ | 736 | Q6ZVD7 | |
| FDLDYESDEFTVDAA | 306 | Q9H5I1 | |
| QVTITEASEDDYEYE | 46 | Q8N0X2 | |
| RIAVEYSDSDDDSEF | 481 | Q9UPY6 | |
| EIENEDEAERVLFSY | 546 | Q8WXW3 | |
| QEEEEEDEEAASRYY | 116 | Q9NW97 | |
| VELTFRTFEVEEEAD | 931 | Q9Y6L7 | |
| RDAIDREVEAVDSEY | 301 | O43847 | |
| RAIYDFEAAEDNELT | 216 | Q92783 | |
| RRASEEEENKASEEY | 131 | Q8IYW5 | |
| DTEYIQDEELRFFSH | 86 | Q9UJW7 | |
| FNERENVEYIEREES | 106 | O95218 | |
| NVEYIEREESDGEYD | 111 | O95218 | |
| LREYDFASESEEDEQ | 1061 | Q96JG9 | |
| EERKQYDSVAFEDVA | 21 | Q9H7R0 | |
| VEETCSYEEAFEALE | 61 | P00734 | |
| NIEDIYEFSSELLED | 151 | Q9H7P9 | |
| ENDDDVYRSLEELAD | 136 | P52735 | |
| LVNDDDEEADDTRYT | 301 | Q8WU90 | |
| LEREECQERNSESYE | 2761 | O15050 | |
| EFREYFEEGLDDQSI | 51 | Q8IWB9 | |
| EEENELVRSEFYYEQ | 1916 | Q68DK2 | |
| EQDTEESDEKQRFSY | 2156 | P15822 | |
| FLASEEERQEYVLSD | 146 | O95932 | |
| DAEYQAFREAITEAV | 76 | Q8N5A5 | |
| DFSHYEKRQEEEESV | 556 | Q9Y5A9 | |
| LDDTYEEEFEEAENI | 396 | A8MT70 | |
| DEEELTSYQNEERNF | 571 | Q8NDX2 | |
| NEDTIEDISYEDTVY | 186 | Q8N402 | |
| EDISYEDTVYDITNE | 191 | Q8N402 | |
| EDTVYDITNEDAVRY | 196 | Q8N402 | |
| LDETVEEYEDENTLF | 131 | Q8N8K9 | |
| DSEILYDVDTENFVR | 536 | O94898 | |
| YQDYEIEISDASEVE | 126 | P20591 | |
| EYLNEDVDARVIEYE | 756 | Q8NEV4 | |
| SYEEISDDERFKIET | 946 | P54296 | |
| DDQEVSEENFEERKY | 761 | Q01538 | |
| ERQYQDFLEDLEEDE | 436 | Q96D46 |